AI assistant
Amplifon — Interim / Quarterly Report 2024
Nov 7, 2024
4030_ir_2024-11-07_815b4370-424b-4165-a6a7-67490ad9b011.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer



| PREFACE 4 |
|---|
| INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2024 5 |
| HIGHLIGHTS 6 |
| MAIN ECONOMIC AND FINANCIAL FIGURES 7 |
| INDICATORS 8 |
| SHAREHOLDER INFORMATION 10 |
| RECLASSIFIED CONSOLIDATED INCOME STATEMENT 12 |
| RECLASSIFIED BALANCE SHEET 15 |
| CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT 17 |
| INCOME STATEMENT REVIEW 18 |
| BALANCE SHEET REVIEW 35 |
| ACQUISITION OF COMPANIES AND BUSINESSES 46 |
| OUTLOOK 47 |
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS AT 30 SEPTEMBER 2024 50 |
| CONSOLIDATED STATEMENT OF FINANCIAL POSITION 50 |
| CONSOLIDATED INCOME STATEMENT 52 |
| STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME 53 |
| STATEMENT OF CHANGES IN CONSOLIDATION EQUITY 54 |
| STATEMENT OF CONSOLIDATED CASH FLOWS 56 |
| SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS 57 |
| NOTES 58 |
| 1. General Information58 |

Interim Financial Report as at 30 September 2024
| 2. | Impacts of the conflict in Middle-East, Ukraine and climate change on the Group's | |
|---|---|---|
| performance and financial position59 | ||
| 3. | Acquisitions e goodwill60 | |
| 4. | Intangible fixed assets with finite useful life63 | |
| 5. | Property, plant, and equipment64 | |
| 6. | Right-of-use assets65 | |
| 7. | Other non-current assets66 | |
| 8. | Share capital and treasury shares67 | |
| 9. | Net financial indebtedness68 | |
| 10. | Financial liabilities71 | |
| 11. | Provision for risks and charges74 | |
| 12. | Lease liabilities 75 |
|
| 13. | Revenues from sales and services75 | |
| 14. | Operating costs, depreciation and impairment, financial income-expenses and taxes76 | |
| 15. | Performance Stock Grant77 | |
| 16. | Non-recurring significant events78 | |
| 17. | Earnings (loss) per share 79 |
|
| 18. | Transactions with parents and other related parties 80 |
|
| 19. | Contingent liabilities 81 |
|
| 20. | Financial risk management 81 |
|
| 21. | Translation of foreign companies' financial statements82 | |
| 22. | Segment reporting 83 |
|
| 23. | Accounting policies 88 |
|
| 24. | Subsequent events93 | |
| ANNEXES | 94 | |
| Consolidation scope 94 |
||
| Declaration in respect of the Consolidated Financial Statements pursuant to Article 154-bis | ||
| of Legislative Decree no. 58/98 99 |
Disclaimer
This report contains forward looking statements ("Outlook") relating to future events and the Amplifon Group's operating, economic and financial results. These forecasts, by definition, contain elements of risk and uncertainty, insofar as they are linked to the occurrence of future events and developments. The actual results may be very different with respect to the original forecast due to several factors, the majority of which are out of the Group's control.


PREFACE
This Interim Financial Report as at 30 September 2024 was prepared in accordance with the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) endorsed by the European Union and should be read together with the Group's consolidated financial statements as at and for the year ended 31 December 2023 that includes additional information on the risks and uncertainties that could impact the Group's operating results or its financial position.

INTERIM MANAGEMENT REPORT AS AT
30 SEPTEMBER 2024

HIGHLIGHTS
In the first nine months of 2024 Amplifon recorded an increase in revenues which was particularly significant in Americas and APAC thanks to high organic growth and acquisitions, with a slight increase in profitability despite what is still a weak European market and the dilution stemming from the decided acceleration in the growth of the direct Miracle-Ear store network in the United States.
| (€ thousands) | First nine months 2024 | First nine months 2023 | ||
|---|---|---|---|---|
| Recurring | Total | Recurring | Total | |
| Economic figures: | ||||
| Revenues from sales and services | 1,744,833 | 1,744,833 | 1,645,065 | 1,645,065 |
| Gross operating profit (loss) (EBITDA) | 412,234 | 407,813 | 385,806 | 372,585 |
| Operating profit (loss) (EBIT) | 191,960 | 187,539 | 192,890 | 179,669 |
| Profit (loss) before tax | 148,363 | 143,942 | 155,997 | 142,776 |
| Group net profit (loss) | 107,379 | 104,181 | 112,815 | 103,438 |
The first nine months of the year closed with:
- Turnover of €1,744,833 thousand, an increase of 6.1% compared to the same period of the prior year (+8.0% at constant exchange rates);
- a gross operating margin (EBITDA) of €407,813 thousand, 9.5% higher than in the nine months of 2023 (+6.9% on a recurring basis);
- Group net profit of €104,181 thousand, an increase of €743 thousand compared to the first nine months of 2023, €5,436 lower (-4.8%) on a recurring basis.
Net financial debt, excluding lease liabilities, amounts to €1,068,279 thousand compared to €852,130 thousand at year-end 2023. Free cash flow reached a positive €50,560 thousand (compared to € 68,772 thousand in the first nine months of the prior year) and was impacted primarily by higher rent and interest payments, as well as greater absorption of working capital. The significant cash-outs for acquisitions, which amounted to €184,077 thousand (€83,243 thousand in the first nine months of 2023), along with the payment of €65,593 thousand in dividends (€65,361 thousand in the comparison period), the purchase of treasury shares for €20,258 thousand (none were purchased in the comparison period) and the positive cash flow generated by other financial assets of €5,562 thousand, bring cash flow for the reporting period to negative €214,292 thousand versus a negative €83,847 thousand in the first nine months of 2023.

MAIN ECONOMIC AND FINANCIAL FIGURES
| (€ thousands) | First nine months 2024 | First nine months 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Non | % on revenues |
Non | % on revenues |
Change % on |
|||||
| Recurring | recurring | Total | recurring | Recurring | recurring | Total | recurring | recurring | |
| Economic figures: | |||||||||
| Revenues from sales and services |
1,744,833 | - | 1,744,833 | 100.0% | 1,645,065 | - | 1,645,065 | 100.0% | 6.1% |
| Gross operating profit (loss) (EBITDA) |
412,234 | (4,421) | 407,813 | 23.6% | 385,806 | (13,221) | 372,585 | 23.5% | 6.9% |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
231,076 | (4,421) | 226,655 | 13.2% | 229,538 | (13,221) | 216,317 | 14.0% | 0.7% |
| Operating profit (loss) (EBIT) |
191,960 | (4,421) | 187,539 | 11.0% | 192,890 | (13,221) | 179,669 | 11.7% | -0.5% |
| Profit (loss) before tax | 148,363 | (4,421) | 143,942 | 8.5% | 155,997 | (13,221) | 142,776 | 9.5% | -4.9% |
| Group net profit (loss) | 107,379 | (3,198) | 104,181 | 6.2% | 112,815 | (9,377) | 103,438 | 6.9% | -4.8% |
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change |
|---|---|---|---|
| Financial figures: | |||
| Non-current assets | 3,172,074 | 2,976,387 | 195,687 |
| Net invested capital | 2,693,482 | 2,451,239 | 242,243 |
| Group net equity | 1,118,112 | 1,100,919 | 17,193 |
| Total net equity | 1,118,265 | 1,101,678 | 16,587 |
| Net financial indebtedness | 1,068,279 | 852,130 | 216,149 |
| Lease liabilities | 506,939 | 497,431 | 9,508 |
| Total lease liabilities and net financial indebtedness | 1,575,217 | 1,349,561 | 225,656 |
| (€ thousands) | First nine months 2024 | First nine months 2023 |
|---|---|---|
| Free cash flow | 50,560 | 68,772 |
| Cash flow generated from (absorbed by) business combinations | (184,077) | (83,243) |
| Cash flow provided by (used in) financing activities | (80,775) | (69,376) |
| Net cash flow from the period | (214,292) | (83,847) |
| Effect of exchange rate fluctuations on the net financial position | (1,857) | (3,793) |
| Net cash flow from the period with changes for exchange rate fluctuations | (216,149) | (87,640) |
- EBITDA is the operating result before charging amortization, depreciation, impairment of both tangible and intangible fixed assets and the right of use depreciation.
- EBITA is the operating result before amortization and impairment of customer lists, trademarks, non-competition agreements and other fixed assets arising from business combinations.
- EBIT is the operating result before financial income and charges and taxes.

- Free cash flow represents the cash flow of operating and investing activities before the cash flows used in acquisitions and payment of dividends and the cash flows from or used in other financing activities.
| 09/30/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|
| Net financial indebtedness (€ thousands) | 1,068,279 | 852,130 | 917,633 |
| Lease liabilities (€ thousands) | 506,939 | 497,431 | 487,635 |
| Total lease liabilities & net financial indebtedness (€ thousands) | 1,575,217 | 1,349,561 | 1,405,268 |
| Net equity (€ thousands) | 1,118,265 | 1,101,678 | 1,070,715 |
| Group Net Equity (€ thousands) | 1,118,112 | 1,100,919 | 1,069,770 |
| Net financial indebtedness/Net Equity | 0.96 | 0.77 | 0.86 |
| Net financial indebtedness/Group Net Equity | 0.96 | 0.77 | 0.86 |
| Net financial indebtedness/EBITDA | 1.78 | 1.50 | 1.63 |
| EBITDA/Net financial expenses | 17.20 | 18.03 | 21.58 |
| Earnings per share (EPS) (€) | 0.46111 | 0.69285 | 0.45805 |
| Diluted EPS (€) | 0.45766 | 0.68809 | 0.63150 |
| EPS (€) adjusted for non-recurring transactions and amortization/depreciation related to purchase price allocations to tangible and intangible assets |
0.62242 | 0.91271 | 0.63150 |
| Group Net Equity per share (€) | 4.958 | 4.880 | 4.744 |
| Period-end price (€) | 25.81 | 31.34 | 28.12 |
| Highest price in period (€) | 35.14 | 36.27 | 36.27 |
| Lowest price in period (€) | 25.74 | 24.49 | 25.02 |
| Share price/net equity per share | 5.205 | 6.422 | 5.928 |
| Market capitalization (€ millions) | 5,819.22 | 7,074.89 | 6,341.36 |
| Number of shares outstanding | 225,501,321 | 225,746,472 | 225,510,487 |
INDICATORS
- Net financial indebtedness/net equity is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to total net equity.
- Net financial indebtedness/Group net equity is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to the Group's net equity.
- Net financial indebtedness/EBITDA is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to recurring operations only, based on pro forma figures in case of significant changes to the structure of the Group).
- EBITDA/net financial expenses ratio is the ratio of EBITDA for the last four quarters (determined with reference to recurring operations only, based on restated figures in case of significant changes to the structure of the Group) to net interest payable and receivable of the same last four quarters.
- Earnings per share (EPS) (€) is the net profit for the period attributable to the parent's ordinary shareholders divided by the weighted average number of shares outstanding during

the period, considering purchases and sales of treasury shares as cancellations or issues of shares, respectively.
- Diluted earnings per share (EPS) (€) is the net profit for the period attributable to the parent's ordinary shareholders divided by the weighted average number of shares outstanding during the period adjusted for the dilution effect of potential shares. In the calculation of outstanding shares, purchases and sales of treasury shares are considered as cancellations and issues of shares, respectively.
- Earnings per share (EPS) adjusted for non-recurring transactions, amortization/depreciation and impairment related to purchase price allocations to tangible and intangible assets (€) is the profit for the period from recurring operations attributable to the parent's ordinary shareholders divided by the weighted average number of outstanding shares in the period adjusted to reflect the amortization of purchase price allocations. When calculating the number of outstanding shares, the purchases and sales of treasury shares are considered cancellations and share issues, respectively.
- Net Equity per share (€) is the ratio of Group equity to the number of outstanding shares.
- Period-end price (€) is the closing price on the last stock exchange trading day of the period.
- Highest price (€) and lowest price (€) are the highest and lowest prices from 2 January to the end of the period.
- Share price/Net equity per share is the ratio of the share closing price on the last stock exchange trading day of the period to net equity per share.
- Market capitalization is the closing price on the last stock exchange trading day of the period multiplied by the number of outstanding shares.
- The number of shares outstanding is the number of shares issued less treasury shares.

SHAREHOLDER INFORMATION
Main shareholders
The main shareholders of Amplifon S.p.A. as at 30 September 2024 are:
42.0% 0.4% 57.6% Ampliter S.r.l. Treasury shares Market
| Shareholder | No. of ordinary shares (*) |
% held | % of the total share capital in voting rights |
|
|---|---|---|---|---|
| Ampliter S.r.l. | 95,165,392 | 42.04% | 59.09% | |
| Treasury shares | 887,299 | 0.39% | 0.28% | |
| Market | 130,335,929 | 57.57% | 40.63% | |
| Total | 226,388,620 | 100.00% | 100.00% |
(*) Number of shares related to the share capital registered with the Company registrar on 30 September 2024
Pursuant to article 2497 of the Italian Civil Code, Amplifon S.p.A. is not subject to management and coordination either by its direct parent Ampliter S.r.l. or its indirect parent.
The shares of the parent Amplifon S.p.A. have been listed on the screen-based stock market Euronext Milano (EXM) since 27 June 2001 and since 10 September 2008 in the STAR segment. Amplifon is also included in the FTSE MIB index and in the Stoxx Europe 600 index.
The chart shows the performance of the Amplifon share price and its trading volumes from 30 December 2023 to 30 September 2024.
As at 30 September 2024 market capitalization was €5,820.19 million.


Dealings in Amplifon shares in the screen-based stock market Euronext Milano (EXM) during the period 30 December 2023 – 30 September 2024, showed:
- average daily value: €18,027,489.90;
-
average daily volume: 579,459 shares;
-
total volume traded of 113,573,890 shares, or 50.37% of the total number of shares comprising the share capital, net of treasury shares.

RECLASSIFIED CONSOLIDATED INCOME STATEMENT
| (€ thousands) | First nine months 2024 | First nine months 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring (*) |
Total | % on | recurring Recurring | Non Recurring(*) Total |
% on recurring |
Change % on recurring |
||
| Revenues from sales and services |
1,744,833 | - | 1,744,833 | 100.0% | 1,645,065 | - | 1,645,065 | 100.0% | 6.1% |
| Operating costs (**) | (1,337,759) | (4,421) (1,342,180) | -76.7% (1,264,767) | (13,221) (1,277,988) | -76,9% | -5.8% | |||
| Other income and costs (**) | 5,160 | - | 5,160 | 0.3% | 5,508 | - | 5,508 | 0,3% | -6.3% |
| Gross operating profit (loss) (EBITDA) |
412,234 | (4,421) | 407,813 | 23.6% | 385,806 | (13,221) | 372,585 | 23.5% | 6.9% |
| Depreciation, amortization and impairment losses on non current assets |
(84,271) | - | (84,271) | -4.8% | (68,360) | - | (68,360) | -4.2% | -23.3% |
| Right-of-use depreciation | (96,887) | - | (96,887) | -5.6% | (87,908) | - | (87,908) | -5.3% | -10.2% |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
231,076 | (4,421) | 226,655 | 13.2% | 229,538 | (13,221) | 216,317 | 14.0% | 0.7% |
| PPA related depreciation, amortization and impairment |
(39,116) | - | (39,116) | -2.2% | (36,648) | - | (36,648) | -2.3% | -6.7% |
| Operating profit (loss) (EBIT) | 191,960 | (4,421) | 187,539 | 11.0% | 192,890 | (13,221) | 179,669 | 11.7% | -0.5% |
| Income, expenses, valuation and adjustments of financial assets |
283 | - | 283 | 0.0% | 210 | - | 210 | 0.0% | 34.8% |
| Net financial expenses | (41,634) | - | (41,634) | -2.4% | (33,410) | - | (33,410) | -2.0% | -24.6% |
| Exchange differences, inflation accounting and Fair Value valuation |
(2,246) | - | (2,246) | -0.1% | (3,693) | - | (3,693) | -0.2% | 39.2% |
| Profit (loss) before tax | 148,363 | (4,421) | 143,942 | 8.5% | 155,997 | (13,221) | 142,776 | 9.5% | -4.9% |
| Tax | (40,850) | 1,223 | (39,627) | -2.3% | (43,179) | 3,844 | (39,335) | -2.6% | 5.4% |
| Net profit (loss) | 107,513 | (3,198) | 104,315 | 6.2% | 112,818 | (9,377) | 103,441 | 6.9% | -4.7% |
| Profit (loss) of minority interests | 134 | - | 134 | 0.0% | 3 | - | 3 | 0.0% | - |
| Net profit (loss) attributable to the Group |
107,379 | (3,198) | 104,181 | 6.2% | 112,815 | (9,377) | 103,438 | 6.9% | -4.8% |
(*) See table at page 14 for details of non-recurring transactions.
(**) It is specified that, on the comparative period, reclassifications between operating costs and other income and costs have been made in order to better represent financial information.

| (€ thousands) | Third Quarter 2024 | Third Quarter 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring (*) |
Total | % on recurring |
Recurring | Non recurring (*) |
Total | % on recurring |
Change % on recurring |
|
| Revenues from sales and services |
567,582 | - | 567,582 | 100.0% | 531,296 | - | 531,296 | 100.0% | 6.8% |
| Operating costs (**) | (453,541) | (955) | (454,496) | -79.9% | (422,283) | (1,937) | (424,221) | -79.5% | -7.4% |
| Other income and costs (**) | 953 | - | 953 | 0.2% | 753 | - | 753 | 0.1% | 26.6% |
| Gross operating profit (loss) (EBITDA) |
114,994 | (955) | 114,039 | 20.3% | 109,765 | (1,937) | 107,828 | 20.7% | 4.8% |
| Depreciation, amortization and impairment losses on non-current assets |
(28,851) | - | (28,851) | -5.1% | (23,010) | - | (23,010) | -4.3% | -25.4% |
| Right-of-use depreciation | (32,834) | - | (32,834) | -5.8% | (29,233) | - | (29,233) | -5.6% | -12.3% |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
53,309 | (955) | 52,354 | 9.4% | 57,522 | (1,937) | 55,585 | 10.8% | -7.3% |
| PPA related depreciation, amortization and impairment |
(13,762) | - | (13,762) | -2.4% | (12,132) | - | (12,132) | -2.3% | -13.4% |
| Operating profit (loss) (EBIT) | 39,547 | (955) | 38,592 | 7.0% | 45,390 | (1,937) | 43,453 | 8.5% | -12.9% |
| Income, expenses, valuation and adjustments of financial assets |
- | - | - | 0.0% | 3 | - | 3 | 0.0% | - |
| Net financial expenses | (15,294) | - | (15,294) | -2.8% | (13,568) | - | (13,568) | -2.6% | -12.7% |
| Exchange differences, inflation accounting and Fair Value valuation |
(789) | - | (789) | -0.1% | 389 | - | 389 | 0.2% | - |
| Profit (loss) before tax | 23,464 | (955) | 22,509 | 4.1% | 32,214 | (1,937) | 30,277 | 6.1% | -27.2% |
| Tax | (6,313) | 245 | (6,068) | -1.1% | (8,708) | 548 | (8,160) | -1.7% | 27.5% |
| Net profit (loss) | 17,151 | (710) | 16,441 | 3.0% | 23,506 | (1,389) | 22,117 | 4.4% | -27.0% |
| Profit (loss) of minority interests |
(330) | - | (330) | -0.1% | 35 | - | 35 | 0.0% | - |
| Net profit (loss) attributable to the Group |
17,481 | (710) | 16,771 | 3.1% | 23,471 | (1,389) | 22,082 | 4.4% | -25.5% |
(*) See table at page 14 for details of non-recurring transactions.
(**) It is specified that, on the comparative period, reclassifications between operating costs and other income and costs have been made in order to better represent financial information.

The costs relating to the non-recurring transactions highlighted above relate specifically to:
- for €1,678 thousand, the costs incurred to define and implement the amendments to the Articles of Incorporation, including the enhanced voting rights, comprising primarily tax, legal and financial consultancies, as well as the expenses related to the organization of the Extraordinary Shareholders Meeting held on 30 April 2024;
- for €1,478 thousand, the second phase of the GAES integration;
- for €1,138 thousand, the notional cost of the free, one-off assignment made by the shareholder Ampliter of its Amplifon shares to the Chief Executive Officer recognized in the reporting period in accordance with IFRS 2 "Share Based Payments";
- for €127 thousand, the Bay Audio integration in Australia.
| (€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| Costs incurred to define and implement amendments to the Articles of Association including the enhanced voting rights |
(1,678) | - |
| GAES second phase integration costs | (1,478) | (1,433) |
| Notional cost of the Amplifon shares assigned by the shareholder Ampliter to the CEO | (1,138) | (11,614) |
| Bay Audio integration costs | (127) | (174) |
| Impact of the non-recurring items on EBITDA | (4,421) | (13,221) |
| Impact of the non-recurring items on EBIT | (4,421) | (13,221) |
| Impact of the non-recurring items on profit before tax | (4,421) | (13,221) |
| Impact of the above items on the tax burden for the period | 1,223 | 3,844 |
| Impact of the non-recurring items on net profit | (3,198) | (9,377) |
| (€ thousands) | Q3 2024 | Q3 2023 |
|---|---|---|
| Costs incurred to define and implement amendments to the Articles of Association including the enhanced voting rights |
- | - |
| GAES second phase integration costs | (755) | (543) |
| Notional cost of the Amplifon shares assigned by the shareholder Ampliter to the CEO | (158) | (1,220) |
| Bay Audio integration costs | (42) | (174) |
| Impact of the non-recurring items on EBITDA | (955) | (1,937) |
| Impact of the non-recurring items on EBIT | (955) | (1,937) |
| Impact of the non-recurring items on profit before tax | (955) | (1,937) |
| Impact of the above items on the tax burden for the period | 245 | 548 |
| Impact of the non-recurring items on net profit | (710) | (1,389) |

RECLASSIFIED BALANCE SHEET
The reclassified Consolidated Balance Sheet aggregates assets and liabilities according to operating functionality criteria, subdivided by convention into the following three key functions: investments, operations and finance.
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change |
|---|---|---|---|
| Goodwill | 1,942,331 | 1,799,574 | 142,757 |
| Customer lists, non-compete agreements, trademarks and location rights | 265,927 | 255,683 | 10,244 |
| Software, licenses, other int.ass, wip and advances | 162,990 | 160,906 | 2,084 |
| Property, plant, and equipment | 243,501 | 221,516 | 21,985 |
| Right of use assets | 487,092 | 478,153 | 8,939 |
| Fixed financial assets (1) | 26,810 | 16,704 | 10,106 |
| Other non-current financial assets (1) | 43,423 | 43,851 | (428) |
| Total fixed assets | 3,172,074 | 2,976,387 | 195,687 |
| Inventories | 92,868 | 88,320 | 4,548 |
| Trade receivables | 220,673 | 231,253 | (10,580) |
| Other receivables | 143,783 | 107,042 | 36,741 |
| Current assets (A) | 457,324 | 426,615 | 30,709 |
| Total assets | 3,629,398 | 3,403,002 | 226,396 |
| Trade payables | (316,965) | (358,955) | 41,990 |
| Other payables (2) | (368,282) | (379,290) | 11,008 |
| Provision for risks (current portion) | (2,148) | (1,268) | (880) |
| Short term liabilities (B) | (687,395) | (739,513) | 52,118 |
| Net working capital (A) - (B) | (230,071) | (312,898) | 82,827 |
| Derivative instruments (3) | 6,632 | 12,933 | (6,301) |
| Deferred tax assets | 82,756 | 82,701 | 55 |
| Deferred tax liabilities | (102,491) | (98,451) | (4,040) |
| Provisions for risks (non-current portion) | (21,811) | (19,379) | (2,432) |
| Employee benefits (non-current portion) | (12,818) | (12,963) | 145 |
| Loan fees (4) | 2,122 | 3,007 | (885) |
| Other long-term payables | (202,911) | (180,098) | (22,813) |
| NET INVESTED CAPITAL | 2,693,482 | 2,451,239 | 242,243 |
| Shareholders' equity | 1,118,112 | 1,100,919 | 17,193 |
| Third parties' equity | 153 | 759 | (606) |
| Net equity | 1,118,265 | 1,101,678 | 16,587 |
| Medium/Long term net financial debt (4) | 726,642 | 719,428 | 7,214 |
| Short term net financial debt (4) | 341,637 | 132,702 | 208,935 |
| Total net financial debt | 1,068,279 | 852,130 | 216,149 |
| Lease liabilities | 506,939 | 497,431 | 9,508 |
| Total lease liabilities & net financial debt | 1,575,217 | 1,349,561 | 225,656 |
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL DEBT | 2,693,482 | 2,451,239 | 242,243 |

Notes for reconciling the condensed balance sheet with the statutory balance sheet:
- (1) "Financial fixed assets" and "Other non-current financial assets" include equity interests valued by using the net equity method, financial assets at fair value through profit and loss and other non-current assets;
- (2) "Other payables" includes other liabilities, accrued liabilities and deferred income, current portion of liabilities for employees' benefits and tax liabilities;
- (3) "Derivatives instruments" includes cash flow hedging instruments not included in the item "Net medium and long-term financial indebtedness";
- (4) The item "loan fees" is presented in the balance sheet as a direct reduction of the short-term and medium/longterm components of the items "financial payables" and "financial liabilities" for the short-term and long-term portions, respectively.

CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT
The condensed consolidated cash flow statement is a summarized version of the reclassified statement of cash flows set out in the following pages and its purpose is, starting from the EBIT, to detail the cash flows from or used in operating, investing and financing activities.
| (€ thousands) | First nine months 2024 | First nine months 2023 |
|---|---|---|
| Operating profit (loss) (EBIT) | 187,539 | 179,669 |
| Amortization, depreciation and write-downs | 220,274 | 192,916 |
| Provisions, other non-monetary items and gain/losses from disposals | 17,024 | 28,735 |
| Net financial expenses | (40,563) | (33,971) |
| Taxes paid | (54,480) | (60,679) |
| Changes in net working capital | (84,087) | (52,970) |
| Cash flow provided by (used in) operating activities before repayment of lease liabilities |
245,707 | 253,700 |
| Repayment of lease liabilities | (96,112) | (85,095) |
| Cash flow provided by (used in) operating activities (A) | 149,595 | 168,605 |
| Cash flow provided by (used in) operating investing activities (B) | (99,035) | (99,833) |
| Free Cash Flow (A) + (B) | 50,560 | 68,772 |
| Net cash flow provided by (used in) acquisitions (C) | (184,077) | (83,243) |
| Cash flow provided by (used in) investing activities (B) + (C) | (283,112) | (183,076) |
| Cash flow provided by (used in) operating activities and investing activities | (133,517) | (14,471) |
| Dividends | (65,593) | (65,361) |
| Treasury Shares | (20,258) | - |
| Fees paid on medium/long-term financing | (104) | (1,413) |
| Capital increases, third parties' contributions and dividends paid by subsidiaries to third parties |
(382) | (137) |
| Hedging instruments | - | (1,483) |
| Change in non-current assets | 5,562 | (982) |
| Net cash flow from the period | (214,292) | (83,847) |
| Net financial indebtedness at the beginning of the period net of lease liabilities | (852,130) | (829,993) |
| Effect of exchange rate fluctuations on net financial debt | (1,857) | (3,793) |
| Changes in net financial debt | (214,292) | (83,847) |
| Net financial indebtedness at the end of the period net of lease liabilities | (1,068,279) | (917,633) |
The impact of non-recurring transactions on free cash flow in the period is shown in the following table.
| (€ thousands) | First nine months 2024 | First nine months 2023 |
|---|---|---|
| Free cash flow | 50,560 | 68,772 |
| Free cash flow generated by non-recurring transactions (see page 46 for details) | (2,053) | (2,740) |
| Free cash flow generated by recurring transactions | 52,613 | 71,512 |

INCOME STATEMENT REVIEW
Consolidated income statement by segment and geographic area
| (€ thousands) | First nine months 2024 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,101,713 | 366,417 | 276,466 | 237 | 1,744,833 |
| Operating costs | (797,387) | (277,727) | (203,190) | (63,876) | (1,342,180) |
| Other income and costs | 3,070 | 2,312 | (326) | 104 | 5,160 |
| Gross operating profit (loss) (EBITDA) | 307,396 | 91,002 | 72,950 | (63,535) | 407,813 |
| Depreciation, amortization and impairment of non-current assets |
(36,356) | (13,288) | (14,287) | (20,340) | (84,271) |
| Right-of-use depreciation | (62,504) | (10,528) | (22,079) | (1,776) | (96,887) |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
208,536 | 67,186 | 36,584 | (85,651) | 226,655 |
| PPA related depreciation, amortization and impairment |
(26,647) | (3,202) | (9,242) | (25) | (39,116) |
| Operating profit (loss) (EBIT) | 181,889 | 63,984 | 27,342 | (85,676) | 187,539 |
| Income, expenses, revaluation and adjustments of financial assets |
- | - | - | - | 283 |
| Net financial expenses | - | - | - | - | (41,634) |
| Exchange differences, inflation accounting and Fair Value valuation |
- | - | - | - | (2,246) |
| Profit (loss) before tax | - | - | - | - | 143,942 |
| Tax | - | - | - | - | (39,627) |
| Net profit (loss) | - | - | - | - | 104,315 |
| Profit (loss) of minority interests | - | - | - | - | 134 |
| Net profit (loss) attributable to the Group | - | - | - | - | 104,181 |
| (€ thousands) | First nine months 2024 - Only recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,101,713 | 366,417 | 276,466 | 237 | 1,744,833 |
| Gross operating profit (loss) (EBITDA) | 308,874 | 91,002 | 73,077 | (60,719) | 412,234 |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
210,014 | 67,186 | 36,711 | (82,835) | 231,076 |
| Operating profit (loss) (EBIT) | 183,367 | 63,984 | 27,469 | (82,860) | 191,960 |
| Profit (loss) before tax | - | - | - | - | 148,363 |
| Net profit (loss) | - | - | - | - | 107,513 |
| Net profit (loss) attributable to the Group | - | - | - | - | 107,379 |
| (€ thousands) | First nine months 2023 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,067,232 | 321,984 | 255,511 | 338 | 1,645,065 |
| Operating costs (*) | (771,871) | (239,671) | (189,209) | (77,237) | (1,277,988) |
| Other income and costs (*) | 3,473 | 1,636 | (10) | 409 | 5,508 |
| Gross operating profit (loss) (EBITDA) | 298,834 | 83,949 | 66,292 | (76,490) | 372,585 |
| Depreciation, amortization and impairment of non-current assets |
(30,769) | (8,919) | (10,329) | (18,343) | (68,360) |
| Right-of-use depreciation | (58,042) | (8,675) | (19,491) | (1,700) | (87,908) |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
210,023 | 66,355 | 36,472 | (96,533) | 216,317 |
| PPA related depreciation, amortization and impairment |
(24,733) | (3,135) | (8,738) | (42) | (36,648) |
| Operating profit (loss) (EBIT) | 185,290 | 63,220 | 27,734 | (96,575) | 179,669 |
| Income, expenses, revaluation and adjustments of financial assets |
- | - | - | - | 210 |
| Net financial expenses | - | - | - | - | (33,410) |
| Exchange differences, inflation accounting and Fair Value valuation |
- | - | - | - | (3,693) |
| Profit (loss) before tax | - | - | - | - | 142,776 |
| Tax | - | - | - | - | (39,335) |
| Net profit (loss) | - | - | - | - | 103,441 |
| Profit (loss) of minority interests | - | - | - | - | 3 |
| Net profit (loss) attributable to the Group | - | - | - | - | 103,438 |
(*) It is specified that, on the comparative period, reclassifications between operating costs and other income and costs have been made in order to better represent financial information.
| (€ thousands) | First nine months 2023 - Only recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,067,232 | 321,984 | 255,511 | 338 | 1,645,065 |
| Gross operating profit (loss) (EBITDA) | 300,267 | 83,949 | 66,465 | (64,875) | 385,806 |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
211,457 | 66,351 | 36,643 | (84,917) | 229,534 |
| Operating profit (loss) (EBIT) | 186,723 | 63,220 | 27,907 | (84,960) | 192,890 |
| Profit (loss) before tax | - | - | - | - | 155,997 |
| Net profit (loss) | - | - | - | - | 112,818 |
| Net profit (loss) attributable to the Group | - | - | - | - | 112,815 |

| (€ thousands) | Third Quarter 2024 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 344,246 | 125,999 | 97,281 | 56 | 567,582 |
| Operating costs | (263,475) | (97,200) | (71,253) | (22,568) | (454,496) |
| Other income and costs | 886 | 491 | (232) | (192) | 953 |
| Gross operating profit (loss) (EBITDA) | 81,657 | 29,290 | 25,796 | (22,704) | 114,039 |
| Depreciation, amortization and impairment of non-current assets |
(12,834) | (4,346) | (4,785) | (6,886) | (28,851) |
| Right-of-use depreciation | (21,049) | (3,542) | (7,643) | (600) | (32,834) |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
47,774 | 21,402 | 13,368 | (30,190) | 52,354 |
| PPA related depreciation, amortization and impairment |
(9,451) | (1,068) | (3,218) | (25) | (13,762) |
| Operating profit (loss) (EBIT) | 38,323 | 20,334 | 10,150 | (30,215) | 38,592 |
| Income, expenses, revaluation and adjustments of financial assets |
- | - | - | - | - |
| Net financial expenses | - | - | - | - | (15,294) |
| Exchange differences, inflation accounting and Fair Value valuation |
- | - | - | - | (789) |
| Profit (loss) before tax | - | - | - | - | 22,509 |
| Tax | - | - | - | - | (6,068) |
| Net profit (loss) | - | - | - | - | 16,441 |
| Profit (loss) of minority interests | - | - | - | - | (330) |
| Net profit (loss) attributable to the Group | - | - | - | - | 16,771 |
| (€ thousands) | Third Quarter 2024 – Only recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 344,246 | 125,999 | 97,281 | 56 | 567,582 |
| Gross operating profit (loss) (EBITDA) | 82,412 | 29,290 | 25,838 | (22,546) | 114,994 |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
48,529 | 21,402 | 13,410 | (30,032) | 53,309 |
| Operating profit (loss) (EBIT) | 39,078 | 20,334 | 10,192 | (30,057) | 39,547 |
| Profit (loss) before tax | - | - | - | - | 23,464 |
| Net profit (loss) | - | - | - | - | 17,151 |
| Net profit (loss) attributable to the Group | - | - | - | - | 17,481 |
| (€ thousands) | Third Quarter 2023 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 331,750 | 109,323 | 90,130 | 93 | 531,296 |
| Operating costs (*) | (250,125) | (82,575) | (66,435) | (25,085) | (424,221) |
| Other income and costs (*) | 720 | 97 | (25) | (40) | 753 |
| Gross operating profit (loss) (EBITDA) | 82,345 | 26,845 | 23,670 | (25,032) | 107,828 |
| Depreciation, amortization and impairment of non-current assets |
(10,486) | (2,859) | (3,130) | (6,535) | (23,010) |
| Right-of-use depreciation | (19,368) | (3,285) | (6,012) | (568) | (29,233) |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
52,491 | 20,701 | 14,528 | (32,135) | 55,585 |
| PPA related depreciation, amortization and impairment |
(8,418) | (873) | (2,841) | - | (12,132) |
| Operating profit (loss) (EBIT) | 44,073 | 19,828 | 11,687 | (32,135) | 43,453 |
| Income, expenses, revaluation and adjustments of financial assets |
- | - | - | - | 3 |
| Net financial expenses | - | - | - | - | (13,568) |
| Exchange differences, inflation accounting and Fair Value valuation |
- | - | - | - | 389 |
| Profit (loss) before tax | - | - | - | - | 30,277 |
| Tax | - | - | - | - | (8,160) |
| Net profit (loss) | - | - | - | - | 22,117 |
| Profit (loss) of minority interests | - | - | - | - | 35 |
| Net profit (loss) attributable to the Group | - | - | - | - | 22,082 |
(*) It is specified that, on the comparative period, reclassifications between operating costs and other income and costs have been made in order to better represent financial information.
| (€ thousands) | Third Quarter 2023 – Only recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 331,750 | 109,323 | 90,130 | 93 | 531,296 |
| Gross operating profit (loss) (EBITDA) | 82,889 | 26,845 | 23,843 | (23,812) | 109,765 |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
53,035 | 20,701 | 14,701 | (30,915) | 57,522 |
| Operating profit (loss) (EBIT) | 44,617 | 19,828 | 11,860 | (30,915) | 45,390 |
| Profit (loss) before tax | - | - | - | - | 32,214 |
| Net profit (loss) | - | - | - | - | 23,506 |
| Net profit (loss) attributable to the Group | - | - | - | - | 23,471 |

Revenues from sales and services
| (€ thousands) | First nine months 2024 |
First nine months 2023 |
Change | Change % |
|---|---|---|---|---|
| Revenues from sales and services |
1,744,833 | 1,645,065 | 99,768 | 6.1% |
| (€ thousands) | Third quarter 2024 | Third quarter 2023 | Change | Change % |
| Revenues from sales and services |
567,582 | 531,296 | 36,286 | 6.8% |
Consolidated revenues from sales and services amounted to €1,744,833 thousand in the first nine months of 2024, an increase of €99,768 thousand (+6.1%) with respect to the first nine months of prior year.
The increase against the first nine months of 2023 is explained for €71,177 thousand (+4.3%) by organic growth and for €59,903 thousand (+3.7%) by acquisitions. The foreign exchange effect was negative for €31,312 thousand (-1.9%).
Revenues of the Argentine subsidiary were impacted by the inflation accounting used pursuant to IAS 29 (Inflation Accounting), which had a positive impact of 0.3% on the Group's organic growth and a negative impact on the exchange rate effect.
The performance was positive in APAC and AMERICAs, thanks to the organic growth and external growth while, EMEA, even if is growing, continues to be a soft market.
In the third quarter alone, consolidated revenues from sales and services amounted to €567,582 thousand, an increase of €36,286 thousand (+6.8%) compared to the third quarter of 2023, explained for €20,764 thousand (+3.9%) by organic growth and for €21,602 thousand (+4.1%) by acquisitions while the foreign exchange effect was negative for €6,080 thousand (-1.2%).
| (€ thousands) | First nine months 2024 |
% on Total | First nine months 2023 |
% on Total | Change | Change % | Exchange diff. | Change % in local currency |
|---|---|---|---|---|---|---|---|---|
| EMEA | 1,101,713 | 63.2% | 1,067,232 | 64.9% | 34,481 | 3.2% | 857 | 3.1% |
| Americas | 366,417 | 21.0% | 321,984 | 19.6% | 44,433 | 13.8% | (28,385) | 22.6% |
| Asia Pacific | 276,466 | 15.8% | 255,511 | 15.5% | 20,955 | 8.2% | (3,784) | 9.7% |
| Corporate | 237 | 0.0% | 338 | 0.0% | (101) | -29.9% | - | -29.9% |
| Total | 1,744,833 | 100.0% | 1,645,065 | 100.0% | 99,768 | 6.1% | (31,312) | 8.0% |
The breakdown of revenues from sales and services by geographic area is shown below.

Europe, Middle-East, Africa
| Period (€ thousand) | 2024 | 2023 | Change | Change % |
|---|---|---|---|---|
| I quarter | 376,058 | 359,707 | 16,351 | 4.5% |
| II quarter | 381,409 | 375,775 | 5,634 | 1.5% |
| I Half Year | 757,467 | 735,482 | 21,985 | 3.0% |
| III quarter | 344,246 | 331,750 | 12,496 | 3.8% |
| First nine months | 1,101,713 | 1,067,232 | 34,481 | 3.2% |
Consolidated revenues from sales and services amounted to €1,101,713 thousand in the first nine months of 2024, an increase of €34,481 thousand (+3.2%) compared to the same period of the prior year, of which €12,455 thousand (+1.2%) is attributable to organic growth. Acquisitions contributed €21,169 thousand (+1.9%) and exchange differences had a positive impact of €857 thousand (+0.1%).
In the third quarter the organic performance reflected the general softness of the reference market, and especially of the French one. On this result impacted, in Spain, some contingent operational challenges, now resolved. The other countries of the area recorded a solid performance.
In the third quarter alone, consolidated revenues from sales and services amounted to €344,246 thousand, an increase of €12,496 thousand (+3.8%) against the comparison period. This increase is explained mainly by acquisitions which contributed €8,220 thousand (+2.5%), while organic growth was positive for €4,273 thousand (+1.3%) and exchange differences were slightly positive at €3 thousand.
Americas
| Period (€ thousand) | 2024 | 2023 | Change | Change % |
|---|---|---|---|---|
| I quarter | 110,821 | 100,864 | 9,956 | 9.9% |
| II quarter | 129,597 | 111,797 | 17,800 | 15.9% |
| I Half Year | 240,418 | 212,661 | 27,757 | 13.1% |
| III quarter | 125,999 | 109,323 | 16,676 | 15.3% |
| First nine months | 366,417 | 321,984 | 44,433 | 13.8% |
Consolidated revenues from sales and services amounted to €366,417 thousand in the first nine months of 2024, an increase of €44,433 thousand (+13.8%) compared to the first nine month of 2023, attributable for €43.566 thousand (+13.5%) to organic growth which was fueled primarily by the outstanding performance of Miracle-Ear Direct Retail and Amplifon Hearing Health Care and for €29,252 thousand (+9.1%) by acquisitions which includes the Uruguayan subsidiaries which were consolidated for the first time. The foreign exchange effect was negative for €28,385 thousand (-8.8%).

Revenues of the Argentine subsidiary were impacted by inflation accounting used in accordance with IAS 29 (Inflation Accounting), which had a positive impact of 1.2% on organic growth and a negative impact on the exchange effect.
In the third quarter alone, consolidated revenues from sales and services amounted to 125,999 thousand, an increase of €16,676 thousand (+15.3%) against the comparison period attributable for 13,253 thousand (+12.1%) to organic growth and for €10,433 thousand (+9.5%) to acquisitions. The exchange effect was negative for €7,010 thousand (-6.3%).
| Period (€ thousand) | 2024 | 2023 | Change | Change % |
|---|---|---|---|---|
| I quarter | 86,164 | 79,595 | 6,569 | 8.3% |
| II quarter | 93,021 | 85,786 | 7,235 | 8.4% |
| I Half Year | 179,185 | 165,381 | 13,804 | 8.3% |
| III quarter | 97,281 | 90,130 | 7,151 | 7.9% |
| First nine months | 276,466 | 255,511 | 20,955 | 8.2% |
Asia Pacific
Revenues from sales and services amounted to €276,466 thousand in the first nine months of 2024, an increase of €20,955 thousand (+8.2%) compared to the same period of 2023 explained for €15,257 thousand (+6.0%) by organic growth and for €9,482 thousand (+3.7%) by acquisitions made in China. The foreign exchange effect was negative for €3,784 thousand (-1.5%).
In the third quarter alone, revenues from sales and services amounted to €97,281 thousand, an increase of €7,151 thousand (+7.9%) attributable for €3,275 thousand (+3.6%) to organic growth and for €2,949 thousand (+3.3%) to acquisitions while the foreign exchange effect was positive for €927 thousand (+1.0%).

Gross operating profit (EBITDA)
| (€ thousand) | First nine months 2024 | First nine months 2023 | ||||
|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | |
| Gross operating profit (loss) (EBITDA) | 412,234 | (4,421) | 407,813 | 385,806 | (13,221) | 372,585 |
| (€ thousand) | Third Quarter 2024 | Third Quarter 2023 | ||||
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | |
| Gross operating profit (loss) (EBITDA) | 114,994 | (955) | 114,039 | 109,765 | (1,937) | 107,828 |
Gross operating profit (EBITDA) amounted to €407,813 thousand in the first nine months of 2024, an increase of €35,228 thousand (+9.5%) with respect to the comparison period. The EBITDA margin came to 23.4%, 0.8 p.p. higher than in the comparison period.
The costs relating to the non-recurring transactions amount to €4,421 thousand. In the first nine months of 2023 non-recurring expenses amounted to €13,221 thousand. See table at page 14 for details of non-recurring transactions.
Net of these items, EBITDA would have been €26,428 thousand (+6.9%) higher than in the first nine months of 2023 with the EBITDA margin up +0.1 p.p.
In the third quarter alone, EBITDA amounted to €114,039 thousand (20.1% of revenues from sales and services), an increase of €6,211 thousand (+5.8%) against the comparison period with a 0.2 p.p. decrease in the EBITDA margin.
The result for the quarter reflects non-recurring expenses of €955 thousand. In the third quarter of 2023 non-recurring expenses amounted to €1,937 thousand. See table at page 14 for details of non-recurring transactions.
Net of this item, recurring EBITDA would have been €5,229 thousand (+4.8%) higher than in the third quarter of 2023 with the EBITDA margin down -0.4 p.p.

| (€ thousands) | First nine months 2024 |
EBITDA Margin |
First nine months 2023 |
EBITDA Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 307,396 | 27.9% | 298,834 | 28.0% | 8,562 | 2.9% |
| Americas | 91,002 | 24.8% | 83,949 | 26.1% | 7,053 | 8.4% |
| Asia Pacific | 72,950 | 26.4% | 66,292 | 25.9% | 6,658 | 10.0% |
| Corporate (*) | (63,535) | -3.6% | (76,490) | -4.6% | 12,955 | 16.9% |
| Total | 407,813 | 23.4% | 372,585 | 22.6% | 35,228 | 9.5% |
| (€ thousands) | Q3 2024 |
EBITDA Margin |
Q3 2023 |
EBITDA Margin |
Change | Change % |
| EMEA | 81,657 | 23.7% | 82,345 | 24.8% | (688) | -0.8% |
| Americas | 29,290 | 23.2% | 26,845 | 24.6% | 2,445 | 9.1% |
| Asia Pacific | 25,796 | 26.5% | 23,670 | 26.3% | 2,126 | 9.0% |
| Corporate (*) | (22,704) | -4.0% | (25,032) | -4.7% | 2,328 | 9.3% |
| Total | 114,039 | 20.1% | 107,828 | 20.3% | 6,211 | 5.8% |
The breakdown of EBITDA by geographic region is shown below.
(*) Centralized costs are shown as a percentage of the Group's total sales.
The breakdown of recurring EBITDA by geographic region is shown below.
| (€ thousands) | First nine months 2024 |
EBITDA Margin |
First nine months 2023 |
EBITDA Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 308,874 | 28.0% | 300,267 | 28.1% | 8,607 | 2.9% |
| Americas | 91,002 | 24.8% | 83,949 | 26.1% | 7,053 | 8.4% |
| Asia Pacific | 73,077 | 26.4% | 66,465 | 26.0% | 6,612 | 9.9% |
| Corporate (*) | (60,719) | -3.5% | (64,875) | -3.9% | 4,156 | 6.4% |
| Total | 412,234 | 23.6% | 385,806 | 23.5% | 26,428 | 6.9% |
| (€ thousands) | Q3 2024 |
EBITDA Margin |
Q3 2023 |
EBITDA Margin |
Change | Change % |
| EMEA | 82,412 | 23.9% | 82,889 | 25.0% | (477) | -0.6% |
| Americas | 29,290 | 23.2% | 26,845 | 24.6% | 2,445 | 9.1% |
| Asia Pacific | 25,838 | 26.6% | 23,843 | 26.5% | 1,995 | 8.4% |
| Corporate (*) | (22,546) | -4.0% | (23,812) | -4.5% | 1,266 | 5.3% |
| Total | 114,994 | 20.3% | 109,765 | 20.7% | 5,229 | 4.8% |
(*) Centralized costs are shown as a percentage of the Group's total sales.

Europe, Middle-East, Africa
Gross operating profit (EBITDA) amounted to €307,396 thousand in the first nine months of 2024, an increase of €8,562 thousand (+2.9%) with respect to the comparison period. The EBITDA margin came to 27.9%, a decrease of 0.1 p.p. compared to the first nine months of 2023.
The result for the reporting period was impacted for €1,478 thousand by non-recurring expenses relating to the second phase of the GAES integration.
In the first nine months of 2023 non-recurring expenses amounted to €1,433 thousand.
Net of this item, EBITDA would have been €8,607 thousand higher (+2.9%) than in the first nine months of 2023 with the EBITDA margin down -0.1 p.p.
In the third quarter alone, EBITDA amounted to €81,657 thousand, a decrease against the comparison period of €688 thousand (-0.8%). The EBITDA margin was 1.1 p.p. lower than in comparison period coming in at 23.7%.
The result for the quarter was impacted for €755 thousand by non-recurring expenses relating to the second phase of the GAES integration. In the third quarter of 2023 non-recurring expenses amounted to €543 thousand.
Net of this item, recurring EBITDA would have been €477 thousand (-0.6%) lower compared to the third quarter of 2023 with the EBITDA margin down -1.1 p.p.
Americas
Gross operating profit (EBITDA) amounted to €91,002 thousand in the first nine months of 2024, an increase of €7,053 thousand (+8.4%) with respect to the comparison period. The EBITDA margin came to 24.8%, down 1.3 p.p. against the third quarter of 2023, stemming from the decided acceleration in the growth of the direct Miracle-Ear store network in the United States In the third quarter alone EBITDA came to €29,290 thousand, an increase of €2,445 thousand (+9.1%) against the comparison period. The EBITDA margin was 1.4 p.p. lower than in the comparison period, coming in at 23.2%.
Asia Pacific
Gross operating profit (EBITDA) amounted to €72,950 thousand in the first nine months of 2024, an increase of €6,658 thousand (+10.0%) with respect to the comparison period. The EBITDA margin came to 26.4%, +0.5 p.p. higher than in the first nine months of 2023.
Non-recurring expenses of €127 thousand were incurred in the reporting period. In the first nine months of 2023 non-recurring expenses amounted to €174 thousand.
Net of this item, EBITDA would have been €6,612 thousand higher (+9.9%) with the EBITDA margin up +0.4 p.p.
In the third quarter alone EBITDA amounted to €25,796 thousand, an increase of €2,126 thousand (+9.0%) with respect to the comparison period.
The EBITDA margin reached 26.5%, an increase of +0.2 p.p. against the comparison period.

Non-recurring expenses, of €42 thousand, relating to the Bay Audio integration were incurred in the reporting period. In the third quarter of 2023 non-recurring expenses amounted to €174 thousand.
Net of these items, recurring EBITDA would have been €1,995 thousand (+8.4%) higher with the EBITDA margin up +0.1 p.p.
Corporate
In the first nine months of 2024 the net cost of centralized corporate functions (corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8 amounted to €63,535 thousand, a decrease of €12,955 thousand (-16.9%) with respect to the same period of the prior year. The EBITDA margin was 3.6 p.p. (1.0 p.p. lower than in the first nine months of 2023).
The result for the reporting period reflects the non-recurring expenses of €2,816 thousand explained for €1,678 thousand by the costs incurred to define and implement the amendments to the Articles of Incorporation, including the enhanced voting rights, comprising primarily the tax, legal and financial consultancies, and for €1,138 thousand by the notional cost recognized in the reporting period in accordance with IFRS 2 "Share Based Payments".
In the first nine months of 2023 non-recurring expenses of €11,614 thousand were also recognized.
Net of these items, costs would have been €4,156 thousand (+6.4%) lower than in the first nine months of 2023, with the margin down by 0.4 p.p.
In the third quarter, the net cost for corporate functions amounted to €22,704 thousand (4.0% of the Group's revenues from sales and services), a decrease of €2,328 thousand (-9.3%) compared to the third quarter of 2023.
The result for the third quarter was impacted for €158 thousand by non-recurring expenses relating to the notional cost recognized in the reporting period in accordance with IFRS 2 "Share Based Payments".
In the third quarter of 2023 non-recurring expenses amounted to €1,220 thousand.
Net of these items, costs would have been €1,266 thousand (+5.3%) lower than in the third quarter of 2023, with the margin down by 0.5 p.p.

Operating Profit (EBIT)
| (€ thousand) | First nine months 2024 | First nine months 2023 | |||||
|---|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | ||
| Operating profit (loss) (EBIT) | 191,960 | (4,421) | 187,539 | 192,890 | (13,221) | 179,669 | |
| Third Quarter 2024 | Third Quarter 2023 | ||||||
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | ||
| 43,453 | |||||||
| (€ thousand) Operating profit (loss) (EBIT) |
39,547 | (955) | 38,592 | 45,390 | (1,937) |
Operating profit (EBIT) amounted to €187,539 thousand in the first nine months of 2024, an increase of €7,870 thousand (+4.4%) with respect to the comparison period. The EBIT margin came to 10.7%, a decrease of 0.2 p.p. against the comparison period.
The reporting period was impacted for €4,421 by non-recurring expenses. In the first nine months of 2023 non-recurring expenses amounted to €13,221 thousand. See table at page 14 for details of non-recurring transactions.
Net of these items, EBIT would have been €930 thousand lower (-0.5%) than in the first nine months of 2023, with the EBIT margin down -0.7 p.p.
With respect to the gross operating profit (EBITDA), EBIT was also impacted by an increase in amortization and depreciation stemming from network expansion, as well as from the right of use assets, from the investments made in innovation and digital transformation and the initial recognition of assets in accordance with Purchase Price Allocation accounting.
In the third quarter alone operating profit (EBIT) amounted to €38,592 thousand, a decrease of €4,861 thousand (-11.2%) with respect to the comparison period. The EBIT margin came to 6.8%, 1.4 p.p. lower in the comparison period.
The reporting period was impacted for €955 thousand by non-recurring expenses. In the third quarter of 2023 non-recurring expenses amounted to €1,937 thousand. See table at page 14 for details of non-recurring transactions.
Net of this item, recurring EBIT would have been €5,843 thousand lower (-12.9%) than in the third quarter of 2023, with the EBIT margin down -1.5 p.p.

| (€ thousands) | First nine months 2024 |
EBIT Margin |
First nine months 2023 |
EBIT Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 181,889 | 16.5% | 185,290 | 17.4% | (3,401) | -1.8% |
| Americas | 63,984 | 17.5% | 63,220 | 19.6% | 764 | 1.2% |
| Asia Pacific | 27,342 | 9.9% | 27,734 | 10.9% | (392) | -1.4% |
| Corporate (*) | (85,676) | -4.9% | (96,575) | -5.9% | 10,899 | 11.3% |
| Total | 187,539 | 10.7% | 179,669 | 10.9% | 7,870 | 4.4% |
| (€ thousand) | Q3 2024 |
EBIT Margin |
Q3 2023 |
EBIT Margin |
Change | Change % |
| EMEA | 38,323 | 11.1% | 44,073 | 13.3% | (5,750) | -13.0% |
| Americas | 20,334 | 16.1% | 19,828 | 18.1% | 506 | 2.6% |
| Asia Pacific | 10,150 | 10.4% | 11,687 | 13.0% | (1,537) | -13.2% |
| Corporate (*) | (30,215) | -5.3% | (32,135) | -6.0% | 1,920 | 6.0% |
The breakdown of EBIT by geographic area is shown below.
(*) Centralized costs are shown as a percentage of the Group's total sales.
The breakdown of EBIT by geographic area with reference to recurring operations is shown below.
| (€ thousands) | First nine months 2024 |
EBIT Margin |
First nine months 2023 |
EBIT Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 183,367 | 16.6% | 186,723 | 17.5% | (3,356) | -1.8% |
| Americas | 63,984 | 17.5% | 63,220 | 19.6% | 764 | 1.2% |
| Asia Pacific | 27,469 | 9.9% | 27,907 | 10.9% | (438) | -1.6% |
| Corporate (*) | (82,860) | -4.7% | (84,960) | -5.2% | 2,100 | 2.5% |
| Total | 191,960 | 11.0% | 192,890 | 11.7% | (930) | -0.5% |
| (€ thousand) | First nine months 2024 |
EBIT Margin |
First nine months 2023 |
EBIT Margin |
Change | Change % |
| EMEA | 39,078 | 11.4% | 44,617 | 13.4% | (5,539) | -12.4% |
| Americas | 20,334 | 16.1% | 19,828 | 18.1% | 506 | 2.6% |
| Asia Pacific | 10,192 | 10.5% | 11,860 | 13.2% | (1,668) | -14.1% |
| Corporate (*) | (30,057) | -5.3% | (30,915) | -5.8% | 858 | 2.8% |
| Total | 39,547 | 7.0% | 45,390 | 8.5% | (5,843) | -12.9% |
(*) Centralized costs are shown as a percentage of the Group's total sales.

Europe, Middle East, Africa
Operating profit (EBIT) amounted to €181,889 thousand in the first nine months of 2024, a decrease of €3,401 thousand (-1.8%) with respect to the comparison period. The EBIT margin came to 16.5%, 0.9 p.p. lower than in the comparison period.
The result was impacted for €1,478 thousand non-recurring expenses. In the first nine months of 2023 non-recurring expenses amounted to €1,433 thousand.
Net of these items, EBIT would have been €3,356 thousand higher (-1.8%) than in the first nine months of 2023, with the EBIT margin down 0.9 p.p.
In the third quarter alone, EBIT was €5,750 thousand (-13.0%) lower than in the comparison period, coming in at €38,323 thousand. The EBIT margin came to 11.1%, 2.2 p.p. lower than in the comparison period.
The result was impacted for €755 thousand by non-recurring expenses. In the third quarter of 2023 non-recurring expenses amounted to €544 thousand.
Net of this item, recurring EBIT would have been €5,539 thousand lower (-12.4%) than in the third quarter of 2023, with the EBIT margin down 2.0 p.p.
Americas
Operating profit (EBIT) amounted to €63,984 thousand in the first nine months of 2024, an increase of €764 thousand (+1.2%) with respect to the comparison period. The EBIT margin was 2.1 p.p. lower than in the first nine months of 2023, coming in at 17.5%.
In the third quarter alone, EBIT rose €506 thousand (+2.6%) to €20,334. The EBIT margin was 2.0 p.p. lower at 16.1%.
Asia Pacific
Operating profit (EBIT) amounted to €27,342 thousand in the first nine months of 2024, a decrease of €392 thousand (-1.4%) with respect to the comparison period. The EBIT margin came to 9.9%, 1.0 p.p. lower than in the first nine month of 2023.
The result of the period was impacted for €127 thousand by non-recurring expenses. In the first nine months of 2023 non-recurring expenses amounted to €174 thousand. Net of these items, EBIT would have been €438 thousand lower (-1.6%), with the EBIT margin down 1.0 p.p.
In the third quarter alone, operating profit (EBIT) amounted to €10,150 thousand, a decrease of €1,537 thousand (-13.2%) with respect to the comparison period. The EBIT margin came to 10.4%, 2.6 p.p. lower than in the third quarter of 2023.
The result for the third quarter of 2024 was impacted for €42 thousand by non-recurring expenses. In the third quarter of 2023 non-recurring expenses amounted to €174 thousand.

Net of these items, EBIT would have been €1,668 thousand lower (-14.1%), with the EBIT margin down 2.7 p.p.
Corporate
The net Corporate costs at the EBIT level amounted to €85,676 thousand in the first nine months of 2024 (-4.9% of the revenues generated by the Group's sales and services), a decrease of €10,899 thousand against the first nine months of 2023.
The result posted in the reporting period was impacted for €2,816 by non-recurring expenses. In the first nine months of 2023 non-recurring expenses amounted to €11,614 thousand. Net of these items, the costs would have been €2,100 thousand lower (-2.5%) with the margin down 0.5 p.p.
In the third quarter alone, the net Corporate costs amounted to €30,215 thousand (-5.3% of the revenues generated by the Group's sales and services), a decrease of €1,920 thousand (-6.0%) compared to the third quarter of 2023.
The third quarter of 2024 was impacted for €158 thousand non-recurring expenses. In the third quarter of 2023 non-recurring expenses amounted to €1,220 thousand.
Net of these items, the costs would have been 858 thousand lower (-2.8%) with the margin down 0.5 p.p.

Profit before taxes
| (€ thousand) | First nine months 2024 | First nine months 2023 | |||||
|---|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | ||
| Profit before taxes | 148,363 | (4,421) | 143,942 | 155,997 | (13,221) | 142,776 | |
| (€ thousand) | Third Quarter 2024 | Third Quarter 2023 | |||||
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | ||
| Profit before taxes | 23,464 | (955) | 22,509 | 32,214 | (1,937) | 30,277 |
Profit before tax amounted to €143,942 thousand in the first nine months of 2024, an increase of €1,166 thousand (+0.8%) against the comparison period, with a gross profit margin of 8.2% (- 0.5 p.p. with respect to the comparison period).
The results for the reporting period were impacted for €4,421 thousand non-recurring expenses. In the first nine months of 2023 non-recurring expenses of €13,221 thousand were incurred. See table at page 14 for details of non-recurring transactions.
On a recurring basis, profit before tax was €7,634 thousand lower (-4.9%) compared to the first nine months of 2023, with the profit margin down 1.0 p.p.
In addition to the change in EBIT described above, this result reflects an increase in net financial expenses of €6,704 thousand. The increase in interest payable linked to both higher average debt (that includes also the IFRS 16 accounting of higher lease liability stemming from the network expansion) as well as increased interest rates compared to first nine month of 2023 were partially offset by lower exchange differences and financial income stemming from the recognition of tax credits for the deferred payment of acquisitions contained in and regulated by Articles 119 and 121 of Legislative Decree n. 34/2020 ("Decreto Rilancio").
In the third quarter alone, profit before tax was €7,768 thousand (-25.7%) lower, coming in at €22,509 thousand. The gross profit margin was 4.0% (-1.7 p.p. compared to the comparison period).
The increase in financial expenses amounted to €2,907 thousand.
The results for the third quarter of 2024 were impacted by 955 thousand by non-recurring expenses. In the third quarter of 2023 non-recurring expenses of €1,937 thousand were incurred. Net of this item, there would have been a decrease of €8,750 thousand (-0.9%) compared to the third quarter of 2023.
The gross profit margin would have reached 4.1% or -2.0 p.p. less than in the third quarter of 2023.

Group net profit
| (€ thousand) | First nine months 2024 | First nine months 2023 | |||||
|---|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | ||
| Group net profit | 107,379 | (3,198) | 104,181 | 112,815 | (9,377) | 103,438 | |
| (€ thousand) | Third Quarter 2024 | Third Quarter 2023 | |||||
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | ||
| Group net profit | 17,481 | (710) | 16,771 | 23,471 | (1,389) | 22,082 |
The Group's net profit came to €104,181 thousand in the first nine months of 2024, an increase of €743 thousand (+0.7%) against the comparison period, with a profit margin of 6.0% (-0.3 p.p. lower against the comparison period).
The result for the reporting period was impacted for €3,198 thousand by the same non-recurring expenses (described above), net of the tax effect. In the first nine months of 2023 net nonrecurring expenses amounted to €9,337 thousand. See table at page 14 for details of nonrecurring transactions.
On a recurring basis, the Group's net profit was €5,436 thousand (-4.8%) lower than in the first nine months of 2023, with the profit margin down 0.7 p.p.
The tax rate was 27.5% in the reporting period compared to 27.6% in the first nine months of 2023.
In the third quarter alone the Group's net profit reached €16,771 thousand (3.0% of revenues from sales and services), showing an decrease of €5,311 thousand (-24.1%) against the comparison period, with the profit margin down -1.2 p.p. Net of the non-recurring expenses, the Group's net profit would have been €5,990 thousand lower (-25.5%), with the profit margin down -1.3 p.p.

BALANCE SHEET REVIEW
Consolidated balance sheet by geographical area (*)
| (€ thousands) | 09/30/2024 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | APAC | Eliminations | Total | |
| Goodwill | 1,028,294 | 294,503 | 619,534 | - | 1,942,331 |
| Non-competition agreements, trademarks, customer lists and lease rights |
182,129 | 30,403 | 53,395 | - | 265,927 |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
124,413 | 30,147 | 8,430 | - | 162,990 |
| Property, plant, and equipment | 163,879 | 37,478 | 42,144 | - | 243,501 |
| Right-of-use assets | 377,716 | 45,522 | 63,854 | - | 487,092 |
| Financial fixed assets | 20,106 | 6,473 | 231 | - | 26,810 |
| Other non-current financial assets | 39,073 | 2,562 | 1,788 | - | 43,423 |
| Non-current assets | 1,935,610 | 447,088 | 789,376 | - | 3,172,074 |
| Inventories | 69,038 | 14,347 | 9,483 | - | 92,868 |
| Trade receivables | 217,189 | 68,356 | 18,819 | (83,691) | 220,673 |
| Other receivables | 117,464 | 16,940 | 9,574 | (195) | 143,783 |
| Current assets (A) | 403,691 | 99,643 | 37,876 | (83,886) | 457,324 |
| Operating assets | 2,339,301 | 546,731 | 827,252 | (83,886) | 3,629,398 |
| Trade payables | (282,495) | (75,884) | (42,277) | 83,691 | (316,965) |
| Other payables | (282,211) | (43,691) | (42,575) | 195 | (368,282) |
| Provisions for risks and charges (current portion) |
(1,544) | (604) | - | - | (2,148) |
| Current liabilities (B) | (566,250) | (120,179) | (84,852) | 83,886 | (687,395) |
| Net working capital (A) - (B) | (162,559) | (20,536) | (46,976) | - | (230,071) |
| Derivative instruments | 6,632 | - | - | - | 6,632 |
| Deferred tax assets | 59,258 | 11,040 | 12,458 | - | 82,756 |
| Deferred tax liabilities | (66,202) | (22,272) | (14,017) | - | (102,491) |
| Provisions for risks and charges (non current portion) |
(19,825) | (1,139) | (847) | - | (21,811) |
| Liabilities for employees' benefits (non current portion) |
(12,037) | (5) | (776) | - | (12,818) |
| Loan fees | 2,122 | - | - | - | 2,122 |
| Other non-current liabilities | (185,846) | (14,600) | (2,465) | - | (202,911) |
| NET INVESTED CAPITAL | 1,557,153 | 399,576 | 736,753 | - | 2,693,482 |
| Group net equity | 1,118,112 | ||||
| Minority interests | 153 | ||||
| Total net equity | 1,118,265 | ||||
| Net medium and long-term financial indebtedness |
726,642 | ||||
| Net short-term financial indebtedness | 341,637 | ||||
| Total net financial indebtedness | 1,068,279 | ||||
| Lease liabilities | 393,491 | 49,490 | 63,958 | 506,939 | |
| Total lease liabilities & net financial indebtedness |
1,575,217 | ||||
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL INDEBTEDNESS |
2,693,482 |
(*) The balance sheet items are analyzed by the Chief Executive Officer and the Top Management by geographical area without separation of the Corporate structures that are natively included in EMEA.
| (€ thousands) | 12/31/2023 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | APAC | Eliminations | Total | |
| Goodwill | 955,383 | 237,178 | 607,013 | - | 1,799,574 |
| Non-competition agreements, trademarks, customer lists and lease rights |
176,887 | 21,126 | 57,670 | - | 255,683 |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
123,344 | 29,520 | 8,042 | - | 160,906 |
| Property, plant, and equipment | 148,081 | 29,929 | 43,506 | - | 221,516 |
| Right-of-use assets | 373,293 | 44,949 | 59,911 | - | 478,153 |
| Financial fixed assets | 3,629 | 12,841 | 234 | - | 16,704 |
| Other non-current financial assets | 39,701 | 2,440 | 1,710 | - | 43,851 |
| Non-current assets | 1,820,318 | 377,983 | 778,086 | - | 2,976,387 |
| Inventories | 70,314 | 8,729 | 9,277 | - | 88,320 |
| Trade receivables | 231,870 | 56,961 | 27,187 | (84,765) | 231,253 |
| Other receivables | 85,597 | 14,464 | 7,176 | (195) | 107,042 |
| Current assets (A) | 387,781 | 80,154 | 43,640 | (84,960) | 426,615 |
| Operating assets | 2,208,099 | 458,137 | 821,726 | (84,960) | 3,403,002 |
| Trade payables | (327,768) | (70,879) | (45,073) | 84,765 | (358,955) |
| Other payables | (293,855) | (43,725) | (41,905) | 195 | (379,290) |
| Provisions for risks and charges (current portion) |
(586) | (682) | - | - | (1,268) |
| Current liabilities (B) | (622,209) | (115,286) | (86,978) | 84,960 | (739,513) |
| Net working capital (A) - (B) | (234,428) | (35,132) | (43,338) | - | (312,898) |
| Derivative instruments | 12,933 | - | - | - | 12,933 |
| Deferred tax assets | 63,112 | 7,307 | 12,282 | - | 82,701 |
| Deferred tax liabilities | (62,023) | (19,725) | (16,703) | - | (98,451) |
| Provisions for risks and charges (non current portion) |
(17,668) | (896) | (815) | - | (19,379) |
| Liabilities for employees' benefits (non current portion) |
(12,119) | (143) | (701) | - | (12,963) |
| Loan fees | 3,007 | - | - | - | 3,007 |
| Other non-current liabilities | (160,811) | (12,853) | (6,434) | - | (180,098) |
| NET INVESTED CAPITAL | 1,412,321 | 316,541 | 722,377 | - | 2,451,239 |
| Group net equity | 1,100,919 | ||||
| Minority interests | 759 | ||||
| Total net equity | 1,101,678 | ||||
| Net medium and long-term financial indebtedness |
719,428 | ||||
| Net short-term financial indebtedness | 132,702 | ||||
| Total net financial indebtedness | 852,130 | ||||
| Lease liabilities | 387,130 | 48,433 | 61,868 | - | 497,431 |
| Total lease liabilities & net financial indebtedness |
1,349,561 | ||||
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL INDEBTEDNESS |
2,451,239 |

Non-Current Assets
Non-current assets amounted to €3,172,074 thousand at 30 September 2024, an increase of €195,687 thousand with respect to the €2,976,387 thousand recorded at 31 December 2023.
The changes in the reporting period are explained (i) for €207,806 thousand by acquisitions made in the first nine months of the year; (ii) for €99,849 thousand by capital expenditure; (iii) for €98,695 thousand by the recognition of right-of-use assets acquired during the year; (iv) for €220,274 thousand, by amortization, depreciation and impairment, including amortization of the right-of-use assets referred to above; (v) for €9,611 thousand by the recognition of tax credits for the deferred payment of acquisitions contained in and regulated by Articles 119 and 121 of Legislative Decree n. 34/2020 (the Relaunch Decree) and foreign exchange differences.
The following table shows the breakdown of non-current assets by geographical area.
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change | |
|---|---|---|---|---|
| Goodwill | 1,028,294 | 955,383 | 72,911 | |
| Non-competition agreements, trademarks, customer lists and lease rights |
182,129 | 176,887 | 5,242 | |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
124,413 | 123,344 | 1,069 | |
| EMEA (*) | Tangible assets | 163,879 | 148,081 | 15,798 |
| Right-of-use assets | 377,716 | 373,293 | 4,423 | |
| Financial fixed assets | 20,106 | 3,629 | 16,477 | |
| Other non-current financial assets | 39,073 | 39,701 | (628) | |
| Non-current assets | 1,935,610 | 1,820,318 | 115,292 | |
| Goodwill | 294,503 | 237,178 | 57,325 | |
| Non-competition agreements, trademarks, customer lists and lease rights |
30,403 | 21,126 | 9,277 | |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
30,147 | 29,520 | 627 | |
| Americas | Tangible assets | 37,478 | 29,929 | 7,549 |
| Right-of-use assets | 45,522 | 44,949 | 573 | |
| Financial fixed assets | 6,473 | 12,841 | (6,368) | |
| Other non-current financial assets | 2,562 | 2,440 | 122 | |
| Non-current assets | 447,088 | 377,983 | 69,105 | |
| Goodwill | 619,534 | 607,013 | 12,521 | |
| Non-competition agreements, trademarks, customer lists and lease rights |
53,395 | 57,670 | (4,275) | |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
8,430 | 8,042 | 388 | |
| Asia Pacific | Tangible assets | 42,144 | 43,506 | (1,362) |
| Right-of-use assets | 63,854 | 59,911 | 3,943 | |
| Financial fixed assets | 231 | 234 | (3) | |
| Other non-current financial assets | 1,788 | 1,710 | 78 | |
| Non-current assets | 789,376 | 778,086 | 11,290 | |
| Total | 3,172,074 | 2,976,387 | 195,687 |
(*) The balance sheet items are analyzed by the Chief Executive Officer and the Top Management by geographical area without separation of the Corporate structures that are natively included in EMEA.

Europe, Middle-East and Africa
Non-current assets amounted to €1,935,610 thousand at 30 September 2024, an increase of €115,292 thousand with respect to the €1,820,318 thousand recorded at 31 December 2023. This increase is explained by:
- for €118,547 thousand, acquisitions made during the reporting period;
- for €60,848 thousand, right-of-use assets acquired in the year as a result of the renewal of existing leases and network expansion.
- for €37,858 thousand, investments in plant, property and equipment, relating primarily to the opening of new stores and the renewal of existing ones, as well as the purchase of hardware needed to implement Group IT projects detailed below;
- for €32,250 thousand, investments in intangible assets, relating to new Front Office solutions and the expansion of the sales network, as well as the continuous implementation and standardization of the Group ERP cloud system;
- for €147,648 thousand, amortization, depreciation and impairment, including amortization of the right-of-use assets referred to above;
- for €13,437 thousand, to other increases stemming mainly from the recognition of acquisitions with deferred payments using tax credits arising from concessions contained in and regulated by Articles 119 and 121 of Law Decree No. 34/2020 ("Decreto Rilancio")
Americas
Non-current assets amounted to €447,088 thousand at 30 September 2024, an increase of €69,105 thousand against the €377,983 thousand recorded at 31 December 2023. This increase is explained:
- for €73,782 thousand, by acquisitions made in the reporting period;
- for €12,492 thousand, by investments in property, plant and equipment, relating to the opening of new stores, and the renewal of existing ones;
- for €11,817 thousand, by right-of-use assets acquired during the year as a result of the renewal of existing leases and network expansion;
- for €5,762 thousand, investments in intangible assets, relating largely to the continuous implementation and standardization of the Group ERP cloud system primarily at the US subsidiaries;
- for €27,018 thousand, by amortization and depreciation, including the amortization of the right-of-use assets referred to above;
- for €7,230 thousand, by foreign exchange losses.

Asia Pacific
Non-current assets amounted to €789,376 thousand at 30 September 2024, an increase of €11,290 thousand against the €778,086 thousand recorded at 31 December 2023. This change is explained by:
- for €26,030 thousand, an increase in right-of-use assets acquired during the year as a result of the renewal of existing leases and network expansion;
- for €15,977 thousand, by acquisitions made in the reporting period;
- for €8,911 thousand, investments in property, plant and equipment, relating mainly to the opening of stores and the renewal of existing ones, as well as the purchase of the hardware needed to implement IT projects;
- for €2,576 thousand, investments in intangible assets relating mainly to the ongoing implementation and standardization of the Group's cloud-based ERP system;
- for €45,608 thousand, amortization and depreciation, including the amortization of the right of-use assets referred to above;
- for €3,404 thousand by other increases relating to foreign exchange gains which mainly affected goodwill.
Net invested capital
Net invested capital amounted to €2,693,482 thousand at 30 September 2024, an increase of €242,243 thousand against the €2,451,239 thousand recorded at 31 December 2023.
This increase is attributable mainly to the change in non-current assets described above, as well as a slight increase in working capital.
The breakdown of net invested capital by geographic area is shown below.
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change |
|---|---|---|---|
| EMEA (*) | 1,557,153 | 1,412,321 | 144,832 |
| Americas | 399,576 | 316,541 | 83,035 |
| Asia Pacific | 736,753 | 722,377 | 14,376 |
| Total | 2,693,482 | 2,451,239 | 242,243 |
(*) The balance sheet items are analyzed by the Chief Executive Officer and the Top Management by geographical area without separation of the Corporate structures that are natively included in EMEA.
Europe, Middle-East and Africa
Net invested capital came to €1,557,153 thousand at 30 September 2024, an increase of €144,832 thousand against the €1,412,321 thousand recorded at 31 December 2023.
In addition to the increase in non-current assets described above, there was an increase in working capital.
Factoring without recourse in the period involved trade receivables with a face value of € 164,640 thousand (€170,930 thousand in the same period of the prior year) and VAT credits with a face value of € 15,671 thousand (€19,055 thousand in the same period of the prior year). As of

Q4 2023 factoring without recourse includes the receivables payable to German insurance companies through specialized intermediaries; the figures in the comparison period were adjusted to reflect this change.
Americas
Net invested capital came to €399,576 thousand at 30 September 2024, an increase of €83,035 thousand against the €316,541 thousand recorded at 31 December 2023.
This increase is attributable mainly to the change in non-current assets along with a slight increase in net working capital. Factoring without recourse in the reporting period involved trade receivables with a face value of €589 thousand (€1,126 thousand in the same period of the prior year).
Asia Pacific
Net invested capital came to €736,753 thousand at 30 September 2024, an increase of €14,376 thousand against the €722,377 thousand recorded at 31 December 2023. Along with a slight decrease in net working capital, there was also a significant decrease in other long-term payables.
Factoring without recourse in the period involved trade receivables with a face value of €3,878 thousand (€5,652 thousand in the same period of the prior year).
Net financial indebtedness
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change |
|---|---|---|---|
| Net medium and long-term financial indebtedness | 726,642 | 719,428 | 7,214 |
| Net short-term financial indebtedness | 509,269 | 326,733 | 182,536 |
| Cash and cash equivalents | (167,632) | (194,031) | 26,399 |
| Net financial indebtedness (A) | 1,068,279 | 852,130 | 216,149 |
| Lease liabilities – current portion | 124,224 | 113,522 | 10,702 |
| Lease liabilities – non-current portion | 382,715 | 383,909 | (1,194) |
| Lease liabilities (B) | 506,939 | 497,431 | 9,508 |
| Total lease liabilities & net financial indebtedness (A)+(B) (C) |
1,575,217 | 1,349,561 | 225,656 |
| Group net equity (D) | 1,118,112 | 1,100,919 | 17,193 |
| Minority interests | 153 | 759 | (606) |
| Net Equity (E) | 1,118,265 | 1,101,678 | 16,586 |
| Financial indebtedness/Group net equity (A/D) | 0.96 | 0.77 | |
| Financial indebtedness/Net equity (A/E) | 0.96 | 0.77 | |
| Financial indebtedness/EBITDA (*) | 1.78 | 1.50 |
(*) Net financial indebtedness/EBITDA is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to recurring operations only, based on pro forma figures in case of significant changes to the structure of the Group).
Net financial debt, excluding lease liabilities, amounts to €1,068,279 thousand compared to €852,130 thousand at year-end 2023. Free cash flow reached a positive €50,560 thousand (compared to € 68,772 thousand in the first nine months of the prior year) and was impacted primarily by higher rent and interest payments, as well as greater absorption of working capital. The significant cash-outs for acquisitions, which amounted to €184,077 thousand (€83,243 thousand in the first nine months of 2023), along with the payment of €65,593 thousand in dividends (€65,361 thousand in the comparison period), the purchase of treasury shares for €20,258 thousand (none were purchased in the comparison period) and the positive cash flow generated by other financial assets of €5,562 thousand, bring cash flow for the reporting period to negative €214,292 thousand versus a negative €83,847 thousand in the first nine months of 2023.
The main transactions occurred during the period are as follows:
- In June 2024 the Group subscribed the last €50 million tranche of the €350 million loan with the European Investment Bank (EIB), of which €300 million was already subscribed, to support innovation and digitalization. This loan increases the available, unutilized irrevocable credit lines which amounted to €675 million at 30 September 2024.
- In September 2024, Crédit Agricole Italia, backed by SACE's Garanzia Futuro, financed for 50 million euros the international roll-out of Amplifon's new store format, aimed at providing consumers with an immersive and completely personalized experience

through visual and digital elements integrated into an innovative and sustainable architectural design.
• In the second quarter, as agreed with the lenders and based on the original loan agreements, the ESG KPI relative to the €560 million in ESG-linked lines of credit were updated to reflect the new targets included in the new sustainability plan.
In addition to the irrevocable credit lines referred to above, at 30 September 2024 the Group also had cash and cash equivalents, as well as other liquid investments, of €167,632 thousand versus total financial indebtedness of €1,236 million, net of lease liabilities.
Medium-Long term net financial debt, excluding lease liabilities, amounted to €726,642 thousand at 30 September 2024 (€719,428 thousand at 31 December 2023) substantially in line with 2023: the reclassification as short-term debt of the portions of long-term debt maturing in the next 12 months and of the deferred payments for acquisition was net by new subscriptions.
The short-term portion of net financial debt, excluding lease liabilities, amounts to €509,269 showing an increase of €182,536 thousand due primarily to hot money transactions and utilization of short-term credit lines temporary coverage of higher total debt.
More specifically, the short-term portion includes mainly other bank debt linked to hot-money transactions and utilization of short-term credit lines (€316,101 thousand), the short-term portions of long-term bank loans (€173,508 thousand), interest payable on other bank borrowings (€2,320 thousand) and the Eurobond (€2,481 thousand) and lastly, the best estimate of the deferred payments for acquisitions (€12,785 thousand).
Net of cash and cash equivalent, short net financial indebtedness amounts to €341,637 thousand, compared to €132,702 of comparison period.
After first nine months of 2024, as of 14th October 2024, Amplifon signed with UniCredit and Cassa Depositi e Prestiti (CDP) €200 million credit facility ESG linked, divided as follows:
€100 million from UniCredit to support the Group's development initiatives and €100 million from CDP which co-financed Amplifon's investments in innovation in Italy, as already done by the loan signed with European Investment Bank (EIB) mentioned above.
In this way, a similar reduction in the use of short-term lines was allowed and a reduction of the net short-term debt to approximately €140 million, aligned with the comparative period.
The chart below shows the debt maturities compared to:
- the €167.6 million in cash and cash equivalents;
- the unutilized portions of irrevocable credit lines which amount to €450 million;
- the unutilized €225 million of the EIB loan taken out to support investments in innovation and digitalization.


Thanks to the subscription in October 2024 of the €200 million loan from Unicredit and CDP mentioned above, the demand share of financial debts would fall from €322 to €122 million, as shown by the "pro-forma" chart below:

Interest payable on financial debt amounted to €28,740 thousand at 30 September 2024 versus €20,579 thousand at 30 September 2023. Interest payable on leases recognized in accordance with IFRS 16 amounted to €13,786 thousand versus €10,846 thousand at 30 September 2023.
Interest receivable on bank deposits came to €2,550 thousand at 30 September 2024 versus €1,543 thousand at 30 September 2023.
The reasons for the changes in net debt are described in the next section on the statement of cash flows.

CASH FLOW STATEMENT
The reclassified statement of cash flows shows the change in net financial indebtedness from the beginning to the end of the period. Pursuant to IAS 7, the consolidated financial statements include a statement of cash flows that shows the change in cash and cash equivalents from the beginning to the end of the period.
| (€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| OPERATING ACTIVITIES: | ||
| Net profit (loss) attributable to the Group | 104,181 | 103,438 |
| Minority interests | 134 | 3 |
| Amortization, depreciation and impairment: | ||
| - Intangible fixed assets | 77,137 | 65,345 |
| - Tangible fixed assets | 46,250 | 39,663 |
| - Right-of-use assets | 96,887 | 87,908 |
| Total amortization, depreciation and impairment | 220,274 | 192,916 |
| Provisions, other non-monetary items and gains/losses from disposals | 17,024 | 28,735 |
| Group's share of the result of associated companies | (283) | (207) |
| Financial income charges | 43,880 | 37,102 |
| Current and deferred income taxes | 39,627 | 39,333 |
| Change in assets and liabilities: | ||
| - Utilization of provisions | (2,365) | (7,356) |
| - (Increase) decrease in inventories | (3,734) | (8,505) |
| - Decrease (increase) in trade receivables | 9,357 | (14,469) |
| - Increase (decrease) in trade payables | (49,324) | 3,011 |
| - Changes in other receivables and other payables | (38,021) | (25,651) |
| Total change in assets and liabilities | (84,087) | (52,970) |
| Dividends collected | - | 3 |
| Net interest charges | (40,563) | (33,974) |
| Taxes paid | (54,480) | (60,679) |
| Cash flow provided by (used in) operating activities before repayment of lease liabilities | 245,707 | 253,700 |
| Repayment of lease liabilities | (96,112) | (85,095) |
| Cash flow generated from (absorbed) by operating activities | 149,595 | 168,605 |
| INVESTING ACTIVITIES: | ||
| Purchase of intangible fixed assets | (40,588) | (51,313) |
| Purchase of property, plant and equipment | (59,261) | (50,347) |
| Consideration from sale of tangible fixed assets and businesses | 814 | 1,827 |
| Cash flow generated from (absorbed) by investing activities | (99,035) | (99,833) |
| Cash flow generated from operating and investing activities (Free Cash Flow) | 50,560 | 68,772 |
| Business combinations (*) | (184,077) | (83,243) |
| Net cash flow generated from acquisitions | (184,077) | (83,243) |
| Cash flow generated from (absorbed) by investing activities and acquisitions | (283,112) | (183,076) |

| (€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| FINANCING ACTIVITIES: | ||
| Derivatives | - | (1,483) |
| Other non-current assets | 5,562 | (982) |
| Fees paid on medium/long-term financing | (104) | (1,413) |
| Treasury shares | (20,258) | - |
| Dividends | (65,593) | (65,361) |
| Capital increases and minority shareholders' contributions and dividends paid to third parties by subsidiaries |
(382) | (137) |
| Cash flow generated from (absorbed) by financing activities | (80,775) | (69,376) |
| Changes in net financial indebtedness net of lease liabilities | (214,292) | (83,847) |
| Net financial indebtedness at the beginning of the period net of lease liabilities | (852,130) | (829,993) |
| Effect of exchange rate fluctuations on net financial debt | (1,857) | (3,793) |
| Changes in net financial debt | (214,292) | (83,847) |
| Net financial indebtedness at the end of the period net of lease liabilities | (1,068,279) | (917,633) |
(*) The item refers to the net cash flows used in the acquisition of businesses and equity investments.
The change in net financial indebtedness of €214,292 thousand is attributable to:
- (i) Investing activities:
- capital expenditure on property, plant and equipment and intangible assets of € 99,849 thousand relating primarily to the new Front-Office solution and network expansions ongoing implementation and standardization of the Group cloud based ERP system;
- acquisitions amounting to €184,077 thousand, including the impact of the acquired companies' debt and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years;
- net proceeds from the disposal of assets of €814 thousand.
- (ii) Operating activities:
- interest payable on financial indebtedness, on leases due to IFRS16 accounting standards application and other net financial expenses for €40,563 thousand;
- payment of taxes amounting to €54,480 thousand;
- payment of principle on lease obligations of €96,112 thousand;
- cash flow generated by current operations of €340,750 thousand.
- (iii) Financing activities:
- dividends distribution for €65,593 thousand;
- fees paid on medium/long-term financing for €104 thousand;
- treasury shares purchase for €20,258 thousand;
- collection of other non-current assets for €5,562 thousand.
- (iv) Net debt was also impacted by exchange losses of €1,857 thousand.

Non-recurring transactions had a negative impact on cash flow of €2,053 thousand, of which €1,481 thousand for costs related to GAES integration, €490 thousand for costs related to define and implement amendments to the Articles of Association and €82 thousand to the integration of Bay Audio.
ACQUISITION OF COMPANIES AND BUSINESSES
During the first nine months of 2024, the Group continued with external growth operations and acquired 365 points of sale, mainly through the acquisitions made in the Uruguayan and Chinese markets and in the American market with two important franchisees' acquisition, for a total investment of €184,077 thousand, including the debt consolidated and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years.
More in detail, in the first nine months of 2024:
- 95 points of sale were acquired in the United States;
- 94 points of sale were acquired in China;
- 58 points of sale were acquired in Germany;
- 43 points of sale were acquired in France;
- 34 points of sale were acquired in Spain
- 23 points of sale were acquired in Uruguay;
- 11 points of sale were acquired in Canada;
- 6 points of sale were acquired in Italy;
- 1 point of sale was acquired in Argentina.

OUTLOOK
In the third quarter of 2024, the European hearing care market was still soft and below expectations, while the US was solid and in line with expectations, even if slower than in the first half.
In the first nine months, despite a market environment characterized by different performances across geographic areas, the Group continued along its path of strong revenue growth. Profitability was higher than in the same period of the prior year, despite, on the one hand, lower operating leverage and higher marketing investments to overcome market softness in EMEA, and, on the other, the dilution effect due to the Miracle-Ear direct retail network accelerated growth and the integration of the recent acquisitions in the United States.
In the fourth quarter of 2024, Amplifon expects:
- the European market to progressively normalize, while the US market is expected to continue to grow, in line with initial expectations;
- to grow faster than the reference market.
In light of the above and assuming that there are no further slowdowns in global economic activity due to, among others, the well-known inflation related issues and the geopolitical situation, for 2024 Amplifon, also with regards to what was previously communicated, expects:
- consolidated revenues to grow high-single-digit growth at constant exchange rates (expect exchange rate EUR/ARS assumed equals to 1,100 as of 31th December 2024), supported by market share gains and bolt-on acquisitions, the latter contributing to revenue growth for at least 3%;
- a recurring EBITDA margin broadly in line with 2023, despite the lower operating leverage and the higher investments in marketing to overcome market softness in EMEA, as well as the dilution effect due to Miracle-Ear direct retail network accelerated growth and the integration of recent acquisitions in the United States.
In the medium-term the Group remains extremely optimistic about its prospects for sustainable growth in sales and profitability, thanks to the fundamentals of the hearing care market and its even stronger competitive positioning.
Milan, October 30th, 2024
CEO
Enrico Vita

49


CONDENSED INTERIM CONSOLIDATED FINANCIAL
STATEMENTS AS AT 30 SEPTEMBER 2024

CONSOLIDATED STATEMENT OF FINANCIAL POSITION(*)
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change | |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets | ||||
| Goodwill | Note 3 | 1,799,574 | 142,757 | |
| Intangible fixed assets with finite useful life | Note 4 | 416,589 | 12,328 | |
| Property, plant, and equipment | 243,501 | 221,516 | 21,985 | |
| Right-of-use assets | Note 6 | 487,092 | 478,153 | 8,939 |
| Equity-accounted investments | 2,724 | 2,444 | 280 | |
| Hedging instruments | 5,753 | 12,933 | (7,180) | |
| Deferred tax assets | 82,756 | 82,701 | 55 | |
| Contract costs | 11,585 | 11,275 | 310 | |
| Other assets | Note 7 | 46,835 | 9,089 | |
| Total non-current assets | 3,260,583 | 3,072,020 | 188,563 | |
| Current assets | ||||
| Inventories | 92,868 | 88,320 | 4,548 | |
| Trade receivables | 220,673 | 231,253 | (10,580) | |
| Contract costs | 7,156 | 6,840 | 316 | |
| Other receivables | 136,610 | 100,184 | 36,426 | |
| Hedging instruments | 2,040 | 549 | 1,491 | |
| Other financial assets | 875 | 901 | (26) | |
| Cash and cash equivalents Note 9 |
166,775 | 193,148 | (26,373) | |
| Total current assets | 626,997 | 621,195 | 5,802 | |
| Total assets | 3,887,580 | 3,693,215 | 194,365 |

| 09/30/2024 | 12/31/2023 | Change | ||
|---|---|---|---|---|
| (€ thousands) | ||||
| LIABILITIES | ||||
| Net Equity | ||||
| Share capital | Note 8 | 4,528 | 4,528 | - |
| Share premium reserve | 202,712 | 202,712 | - | |
| Treasury shares | (24,620) | (17,495) | (7,125) | |
| Other reserves | (70,274) | (53,608) | (16,666) | |
| Retained earnings | 901,585 | 809,643 | 91,942 | |
| Profit (loss) for the period | 104,181 | 155,139 | (50,958) | |
| Group net equity | 1,118,112 | 1,100,919 | 17,193 | |
| Minority interests | 153 | 759 | (606) | |
| Total net equity | 1,118,265 | 1,101,678 | 16,587 | |
| Non-current liabilities | ||||
| Medium/long-term financial liabilities | Note 10 | 719,749 | 710,267 | 9,482 |
| Lease liabilities | Note 12 | 382,715 | 383,909 | (1,194) |
| Provisions for risks and charges | Note 11 | 21,811 | 19,379 | 2,432 |
| Liabilities for employees' benefits | 12,818 | 12,963 | (145) | |
| Deferred tax liabilities | 102,491 | 98,451 | 4,040 | |
| Payables for business acquisitions | 5,725 | 7,229 | (1,504) | |
| Contract liabilities | 162,912 | 153,716 | 9,196 | |
| Other long-term liabilities | 39,998 | 26,379 | 13,619 | |
| Total non-current liabilities | 1,448,219 | 1,412,293 | 35,926 | |
| Current liabilities | ||||
| Trade payables | 316,965 | 358,955 | (41,990) | |
| Payables for business acquisitions | 12,785 | 9,554 | 3,231 | |
| Contract liabilities | 119,954 | 120,043 | (89) | |
| Tax liabilities | 61,786 | 74,433 | (12,647) | |
| Other payables | 182,523 | 181,101 | 1,422 | |
| Hedging instruments | 341 | 242 | 99 | |
| Provisions for risks and charges | Note 11 | 2,148 | 1,268 | 880 |
| Liabilities for employees' benefits | 4,176 | 3,713 | 463 | |
| Short-term financial liabilities | Note 10 | 496,194 | 316,413 | 179,781 |
| Lease liabilities | Note 12 | 124,224 | 113,522 | 10,702 |
| Total current liabilities | 1,321,096 | 1,179,244 | 141,852 | |
| TOTAL LIABILITIES | 3,887,580 | 3,693,215 | 194,365 |
(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 18 for more details

CONSOLIDATED INCOME STATEMENT(*)
| (€ thousands) | First nine months 2024 | First nine months 2023 | ||||||
|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | Change | ||
| Revenues from sales and services | Note 13 | 1,744,833 | - | 1,744,833 | 1,645,065 | - | 1,645,065 | 99,768 |
| Operating costs (**) | Note 14 | (1,337,759) | (4,421) | (1,342,180) | (1,264,767) | (13,221) | (1,277,988) | (64,192) |
| Other income and costs (**) | 5,160 | - | 5,160 | 5,508 | - | 5,508 | (348) | |
| Gross operating profit (EBITDA) | 412,234 | (4,421) | 407,813 | 385,806 | (13,221) | 372,585 | 35,228 | |
| Amortization, depreciation and impairment |
||||||||
| Amortization of intangible fixed assets | Note 4 | (77,036) | - | (77,036) | (65,319) | - | (65,319) | (11,717) |
| Depreciation of property, plant, and equipment |
Note 5 | (45,663) | - | (45,663) | (39,486) | - | (39,486) | (6,177) |
| Right-of-use depreciation | Note 6 | (96,887) | - | (96,887) | (87,908) | - | (87,908) | (8,979) |
| Impairment losses and reversals of non-current assets |
(688) | - | (688) | (203) | - | (203) | (485) | |
| (220,274) | - | (220,274) | (192,916) | - | (192,916) | (27,358) | ||
| Operating result | 191,960 | (4,421) | 187,539 | 192,890 | (13,221) | 179,669 | 7,870 | |
| Financial income, expenses and value adjustments to financial assets |
||||||||
| Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
283 | - | 283 | 210 | - | 210 | 73 | |
| Interest income and expenses | (26,190) | - | (26,190) | (19,036) | - | (19,036) | (7,154) | |
| Interest expenses on lease liabilities | (13,786) | - | (13,786) | (10,846) | - | (10,846) | (2,940) | |
| Other financial income and expenses | (1,658) | - | (1,658) | (3,528) | - | (3,528) | 1,870 | |
| Exchange gains and losses, and inflation accounting |
(2,759) | - | (2,759) | (4,438) | - | (4,438) | 1,679 | |
| Gain (loss) on assets accounted at fair value |
513 | - | 513 | 745 | - | 745 | (232) | |
| (43,597) | - | (43,597) | (36,893) | - | (36,893) | (6,704) | ||
| Profit (loss) before tax | 148,363 | (4,421) | 143,942 | 155,997 | (13,221) | 142,776 | 1,166 | |
| Current and deferred income tax | ||||||||
| Current tax | (39,666) | 1,223 | (38,443) | (50,062) | 3,844 | (46,218) | 7,775 | |
| Deferred tax | (1,184) | - | (1,184) | 6,883 | - | 6,883 | (8,067) | |
| (40,850) | 1,223 | (39,627) | (43,179) | 3,844 | (39,335) | (292) | ||
| Net profit (loss) | 107,513 | (3,198) | 104,315 | 112,818 | (9,377) | 103,441 | 874 | |
| Net profit (loss) attributable to Minority interests |
134 | - | 134 | 3 | - | 3 | 131 | |
| Net profit (loss) attributable to the Group |
107,379 | (3,198) | 104,181 | 112,815 | (9,377) | 103,438 | 743 |
(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 18 for more details.
(**) It is specified that, on the comparative period reclassifications between "Operating costs" and "Other income and costs" have been made in order to better represent financial information.
| Earnings per share (€ per share) | Note 17 | First nine months 2024 | First nine months 2023 |
|---|---|---|---|
| Earnings per share - Basic - Diluted |
0.46111 0.45766 |
0.46167 0.45805 |

STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME
| (€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| Net income (loss) for the period | 104,315 | 103,441 |
| Other comprehensive income (loss) that will not be reclassified subsequently to profit or loss: |
||
| Remeasurement of defined benefit plans | (423) | (943) |
| Tax effect on components of other comprehensive income that will not be reclassified subsequently to profit or loss |
94 | 201 |
| Total other comprehensive income (loss) that will not be reclassified subsequently to profit or loss after the tax effect (A) |
(329) | (742) |
| Other comprehensive income (loss) that will be reclassified subsequently to profit or loss: | ||
| Gains/(losses) on cash flow hedging instruments | (6,301) | (6,694) |
| Gains/(losses) from Foreign Currency Basis Spread on hedging instruments | - | 516 |
| Gains/(losses) on exchange differences from translation of financial statements of foreign entities |
(9,422) | (41,167) |
| Tax effect on components of other comprehensive income that will be reclassified subsequently to profit or loss |
1,512 | 1,482 |
| Total other comprehensive income (loss) that will be reclassified subsequently to profit or loss after the tax effect (B) |
(14,211) | (45,863) |
| Total other comprehensive income (loss) (A)+(B) | (14,540) | (46,605) |
| Comprehensive income (loss) for the period | 89,775 | 56,836 |
| Attributable to the Group | 89,827 | 57,116 |
| Attributable to Minority interests | (52) | (280) |

STATEMENT OF CHANGES IN CONSOLIDATION EQUITY
| (€ thousands) | Share capital |
Share premium reserve |
Legal reserve |
Other reserves |
Treasury shares reserve |
Stock grant reserve |
|---|---|---|---|---|---|---|
| Balance at 01/01/2023 | 4,528 | 202,712 | 934 | 3,636 | (49,895) | 35,182 |
| Allocation of profit (loss) for 2022 | ||||||
| Share capital increase | ||||||
| Treasury shares | ||||||
| Dividend distribution | ||||||
| Notional cost of stock grants | 22,758 | |||||
| Other changes | 25,970 | (18,467) | ||||
| - Stock Grant | 25,970 | (18,467) | ||||
| - Inflation accounting | ||||||
| - Other changes | ||||||
| Total comprehensive income (loss) for the period | ||||||
| - Hedge accounting | ||||||
| - Actuarial gains (losses) | ||||||
| - Translation differences | ||||||
| - Profit for the first nine months of 2023 | ||||||
| Balance at 30 September 2023 | 4,528 | 202,712 | 934 | 3,636 | (23,925) | 39,473 |
| (€ thousands) | Share capital | Share premium reserve |
Legal reserve |
Other reserves |
Treasury shares reserve |
Stock grant reserve |
|---|---|---|---|---|---|---|
| Balance at 01/01/2024 | 4,528 | 202,712 | 934 | 3,636 | (17,495) | 41,299 |
| Allocation of profit (loss) for 2023 | ||||||
| Share capital increase | ||||||
| Treasury shares | (20,258) | |||||
| Dividend distribution | ||||||
| Notional cost of stock grants | 13,610 | |||||
| Other changes | 13,133 | (15,922) | ||||
| - Stock Grant | 13,133 | (15,922) | ||||
| - Inflation accounting | ||||||
| - Other changes | ||||||
| Total comprehensive income (loss) for the period |
||||||
| - Hedge accounting | ||||||
| - Actuarial gains (losses) | ||||||
| - Translation differences | ||||||
| - Profit for the first nine months of 2024 | ||||||
| Balance at 30 September 2024 | 4,528 | 202,712 | 934 | 3,636 | (24,620) | 38,987 |

| Cash flow hedge reserve |
Foreign Curr. Basis Spread Reserve |
Actuarial gains | and losses | Retained earnings |
Translation differences |
Profit (loss) for the period |
Total Shareholders' equity |
Minority interests |
Total net equity |
|---|---|---|---|---|---|---|---|---|---|
| 19,913 | (392) | 2,782 | 691,409 | (50,825) | 178,525 | 1,038,509 | 1,841 | 1,040,350 | |
| 178,525 | (178,525) | - | - | ||||||
| - | - | ||||||||
| - | - | ||||||||
| (65,361) | (65,361) | (65,361) | |||||||
| 22,758 | 22,758 | ||||||||
| 9,245 | 16,748 | (616) | 16,132 | ||||||
| (4,138) | 3,365 | 3,365 | |||||||
| 14,429 | 14,429 | 14,429 | |||||||
| (1,046) | (1,046) | (616) | (1,662) | ||||||
| (5,088) (5,088) |
392 392 |
(742) | (40,884) | 103,438 | 57,116 (4,696) |
(280) | 56,836 (4,696) |
||
| (742) | (742) | (742) | |||||||
| (40,884) | (40,884) | (283) | (41,167) | ||||||
| 103,438 | 103,438 | 3 | 103,441 | ||||||
| 14,825 | - | 2,040 | 813,818 | (91,709) | 103,438 | 1,069,770 | 945 | 1,070,715 | |
| Cash flow | Actuarial gains | Retained | Translation | Profit (loss) for | Total Shareholders' |
Minority | Total net | ||
| hedge reserve | and losses | earnings | differences | the period | equity | interests | equity | ||
| 9,888 | (957) | 809,643 | (108,408) | 155,139 | 1,100,919 | 759 | 1,101,678 | ||
| 155,139 | (155,139) | - | - | ||||||
| - | - | ||||||||
| (65,593) | (20,258) (65,593) |
(20,258) (65,593) |
|||||||
| 13,610 | 13,610 | ||||||||
| 2,396 | (393) | (554) | (947) | ||||||
| 1,486 | (1,303) | (1,303) | |||||||
| 14,848 | 14,848 | 14,848 | |||||||
| (13,938) | (13,938) | (554) | (14,492) | ||||||
| (4,789) | (329) | (9,236) | 104,181 | 89,827 | (52) | 89,775 | |||
| (4,789) | (4,789) | (4,789) | |||||||
| (329) | (329) | (329) | |||||||
| (9,236) | (9,236) | (186) | (9,422) | ||||||
| 104,181 | 104,181 | 134 | 104,315 | ||||||
| 5,099 | (1,286) | 901,585 | (117,644) | 104,181 | 1,118,112 | 153 | 1,118,265 |

STATEMENT OF CONSOLIDATED CASH FLOWS
| OPERATING ACTIVITIES Net profit (loss) 104,315 103,441 Amortization, depreciation and impairment: - intangible fixed assets 77,137 65,345 - property, plant, and equipment 46,250 39,663 - right-of-use assets 96,887 87,908 Provisions, other non-monetary items and gain/losses from disposals 17,024 28,735 Group's share of the result of associated companies (283) (207) Financial income and expenses 43,880 37,102 Current and deferred taxes 39,627 39,333 Cash flow from operating activities before change in net working capital 424,837 401,320 Utilization of provisions (2,365) (7,356) (Increase) decrease in inventories (3,734) (8,505) Decrease (increase) in trade receivables 9,357 (14,469) Increase (decrease) in trade payables (49,324) 3,011 Changes in other receivables and other payables (38,021) (25,651) Total change in assets and liabilities (84,087) (52,970) Dividends received - 3 Interest received (paid) (38,160) (34,120) Taxes paid (54,480) (60,679) Cash flow generated from (absorbed by) operating activities (A) 248,110 253,554 INVESTING ACTIVITIES: Purchase of intangible fixed assets (40,588) (51,313) Purchase of tangible fixed assets (59,261) (50,347) Consideration from sale of non-current assets 814 1,827 Cash flow generated from (absorbed by) operating investing activities (B) (99,035) (99,833) Purchase of subsidiaries and business units net of cash and cash equivalents acquired or (184,077) (83,243) dismissed Increase (decrease) in payables for business acquisitions 4,235 (13,993) Cash flow generated from (absorbed by) acquisition activities (C) (179,842) (97,236) Cash flow generated from (absorbed by) investing activities (B)+(C) (278,877) (197,069) FINANCING ACTIVITIES: Increase (decrease) in financial payables 183,610 67,953 (Increase) decrease in financial receivables 24 (829) Principal portion of lease payments (96,112) (85,095) Hedging instruments - (1,483) Fees paid on long-term borrowings (104) (1,413) Other non-current assets and liabilities 5,562 (982) Dividend distributed (65,593) (65,361) Treasury shares purchase (20,258) - Capital increases and minority shareholders' contributions and dividends paid to third (382) (137) parties by subsidiaries Cash flow generated from (absorbed by) financing activities (D) 6,747 (87,347) Net increase in cash and cash equivalents (A)+(B)+(C)+(D) (24,020) (30,862) |
(€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|---|

| (€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| Cash and cash equivalents at beginning of period | 193,148 | 179,654 |
| Effect of exchange rate fluctuations on cash & cash equivalents | (2,353) | (2,025) |
| Flows of cash and cash equivalents | (24,020) | (30,862) |
| Cash and cash equivalents at end of period | 166,775 | 146,767 |
Related-party transactions relate to lease of the main office and certain stores, to recharges of maintenance costs and general services of the above-mentioned buildings and to commercial transactions, personnel costs and loans. Such operations are detailed in Note 18.
SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS
The fair values of the assets and liabilities acquired are summarized in the table below:
| (€ thousands) | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| - Goodwill | 137,452 | 63,481 |
| - Customer lists | 45,072 | 22,897 |
| - Trademarks, licenses and non-competition agreements | 1,508 | 1 |
| - Other intangible fixed assets | 4,470 | 502 |
| - Property, plant, and equipment | 9,087 | 4,979 |
| - Right-of-use assets | 9,746 | 938 |
| - Current assets | 15,964 | 6,189 |
| - Provision for risks and charges | (1,865) | 3 |
| - Current liabilities | (26,153) | (8,348) |
| - Other non-current assets and liabilities | (22,113) | (6,172) |
| - Third parties equity | 14,088 | 1,645 |
| Total investments | 187,256 | 86,115 |
| Net financial debt acquired | 3,517 | 976 |
| Total business combinations | 190,773 | 87,091 |
| (Increase) decrease in payables through business acquisition | (4,235) | 13,993 |
| Cash flow absorbed by (generated from) acquisitions | 186,538 | 101,084 |
| (Cash and cash equivalents acquired) | (6,696) | (3,848) |
| Net cash flow absorbed by (generated from) acquisitions | 179,842 | 97,236 |

NOTES
1. General Information
The Amplifon Group is global leader in the distribution of hearing solutions and the fitting of customized products.
The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.04% as at 30 September 2024), held by Amplifin S.r.l, which is owned at 100% by Susan Carol Holland. As a result of increased voting rights, at 30 September 2024 Ampliter S.r.l. held 59.09% of the voting rights. On 30 April 2024 the Extraordinary Shareholders' Meeting approved a few amendments to the Articles of Association, including enhanced voting rights as a result of which voting rights may be increased by one vote per share held for each 12-month period in which the shares are owned without interruption for a total of up to 10 votes per share based on a mechanism calling for a gradual increase. As none of the conditions for termination materialized, the amendments took full effect.
The condensed interim consolidated financial report as at 30 September 2024 was prepared in accordance with International Accounting Standards, as well as the implementation regulations set out in Article 9 of Legislative Decree no. 38 of 28 February 2005. These standards include the IAS and IFRS issued by the International Accounting Standard Board, as well as the SIC and IFRIC interpretations issued by the International Financial Reporting Interpretations Committee, which were endorsed in accordance with the procedure set out in Article 6 of Regulation (EC) no. 1606 of 19 July 2002 by 30 September 2024. The International Accounting Standards endorsed after that date and before the preparation of this report were adopted in the preparation of the condensed interim consolidated financial report only if early adoption is allowed by the Endorsing Regulation and the standard itself and if the Group had elected to do so.
The condensed interim consolidated financial statements at 30 September 2024 was prepared in accordance with IAS 34 "Interim Financial Reporting" and does not include all the additional information required by the annual financial statements and must be read together with the Group's annual consolidated financial statements at 31 December 2023.
The publication of the condensed interim consolidated financial statements of the Amplifon Group at 30 September 2024 was authorized by a resolution of the Board of Directors of 30 October 2024 which approved their publication.
According to the Consob Communication of 28 July 2006, it is specified that during the first nine months of 2024 the Group did not carry out atypical and/or unusual transactions, as defined by the Communication itself.

2. Impacts of the conflict in Middle-East, Ukraine and climate change on the Group's performance and financial position
The geopolitical uncertainty continues and persists due to the conflicts underway in the Middle East and Ukraine. The situation in the Middle East is currently extremely tense and complex. In the last quarter tensions spread to nearby countries like Lebanon and Iran. This situation could have significant repercussions in the region, but also globally, above all for energy and the financial markets. The Group, however, only has about 25 points of sale in this geographic area (in Israel) which generate sales equal to approximately 1% of annual consolidated revenues and limited activities in surrounding countries (Egypt) and does not have any business activities, direct or indirect, in either Lebanon or Iran. As for the conflict between Ukraine and Russia, the situation remains tense and has not changed significantly since the prior quarter. The Group has no business activities, direct or indirect, in either Ukraine, Russia or Byelorussia and limited activities in surrounding countries (Poland and Hungary).
In the first nine months of the year, the hearing aid market was characterized by performances that differed across the geographic areas. The US market was solid, even if slower than in the first quarter, while the European market was softer than expected, particularly as of the second quarter. The Group recognizes that the current global and geopolitical uncertainties, with inflation that has yet to stabilize, could cause a few potential customers to postpone nonessential purchases in the near-term, even if hearing aids are non-discretional products which meet medium-term needs and benefit people's physical, emotional and relational health significantly. Customers are also assisted by public and private insurances, as well as consumer loans. While the Group monitors the changing macroeconomic environment constantly, it cannot exclude the possibility of further slowdowns in the demand for its services and products even though in the past the sector has shown resilience in periods of economic crisis and geopolitical uncertainty.
With regard to climate change, the Group's business model is based on providing retail hearing solutions. The goals, therefore, connected to transitioning to alternative sources of energy and the actions needed to address climate change are pursued through the steps taken by the Group to improve the energy efficiency of its business activities, as well as report on the greenhouse gas emissions generated along the value chain. Toward this end, the Group is committed to defining and presenting short-term targets for reducing emissions aligned with the Science-Based Target Initiative (SBTi) by 2025.
Furthermore, the Group's activities and business model do not entail significant exposure to the environmental risks connected specifically to climate change.

3. Acquisitions e goodwill
The Group continued its own balancing strategy between internal and external growth during the first nine months of 2024 acquiring 365 points of sale. In detail, there were 141 points of sale purchased in EMEA, 130 in Americas (with the entrance in Uruguayan market and acquisition of two of main franchisees in the United States) and 94 in Asia Pacific.
The total investment, including the indebtedness consolidated and the best estimate of the net change in the earn-out linked to sales and profitability targets payable over the next few years, amounted to €184,077 thousand.
The changes in goodwill and amounts recognized as a result of the acquisitions made in the period are reported in the table below and shown by groups of Cash Generating Units.
| (€ thousands) | Net carry at 12/31/2023 |
Business combinations |
Disposals | Impairment | Other net changes | Net carry at 09/30/2024 |
|---|---|---|---|---|---|---|
| EMEA | 955,383 | 73,085 | - | - | (174) | 1,028,294 |
| AMERICAS | 237,178 | 55,153 | - | - | 2,172 | 294,503 |
| APAC | 607,013 | 9,214 | - | - | 3,307 | 619,534 |
| Total | 1,799,574 | 137,452 | - | - | 5,305 | 1,942,331 |
"Business combination" refers to the temporary allocation to goodwill of the portion of the purchase price paid, including deferments and contingent consideration (earn-outs), which is not directly attributable to the fair value of assets and liabilities, but is based on the positive contribution to cash flows that is expected to be made for an indefinite period of time. "Other net changes" refers almost entirely to foreign exchange differences.
Identification of the Groups of Cash Generating Units
For the purposes of impairment testing the total goodwill stemming from the cost incurred for a business combination was allocated to groups of Cash Generating Units; these groups of Cash Generating Units were identified by region and benefit from synergies, as well as shared policies, and are autonomous in the management and use of resources.
The assets allocated to the groups of Cash Generating Units and the methods used to determine these groups are the same as those applied to the financial Statements as at 31 December 2023.
The groups of Cash Generating Units recognized to perform impairment are:
- EMEA which includes Italy, France, the Netherlands, Germany, Belgium, Switzerland, Spain, Portugal, the UK, Hungary, Poland, Israel and Egypt;
- AMERICAS which includes both the single businesses through which operations are carried out in the US market (Franchising, Retail and Managed Care) and the countries (Canada, Argentina, Chile, Mexico, Panama, Ecuador, Colombia and Uruguay);
- ASIA PACIFIC which includes Australia, New Zealand, India and China.

The recoverable value of goodwill is determined based on the value in use or, if the latter is less than book value, on fair value. As at 31 December 2023 the management's valuations were made taking into consideration the value in use. No loss in value was identified as a result of the impairment tests conducted at 31 December 2023.
The Group tests for impairment of goodwill once a year and in the event of any impairment indicators.
In the first nine months of 2024, overall, the Group posted results (revenues and EBITDA) which were higher than in the prior year in all geographic areas. While positive and increased, these results do not fully meet the budget targets, specifically in EMEA, but there are gaps in APAC and AMERICAS, also. These shortfalls are largely offset by greater corporate efficiency. The Group EBITDA margin is, in fact, above budget. The decrease in revenues is more than offset by the decrease in interest and discount rates. The sensitivity analyses carried out show that the headroom in all areas has increased. There is ample headroom, therefore, to absorb any significant changes in cash flows in the future.
No indicators of impairment emerged, therefore, no specific impairment tests were made. For the purposes of measuring the recoverable value of goodwill reference should be made to the impairment tests reported in the Annual Report 2023.

A summary of the book value and the fair value of assets and liabilities, deriving from the temporary allocation of the purchase price made as a result of business combinations and the purchase of minority interests in subsidiaries, is provided in the following table.
| (€ thousands) | EMEA | Americas | APAC | Total |
|---|---|---|---|---|
| Cost of acquisitions of the period | 91,714 | 65,477 | 30,065 | 187,256 |
| Assets and liabilities acquired – Book value | ||||
| Current assets | 6,044 | 3,224 | - | 9,268 |
| Current liabilities | (11,759) | (5,182) | - | (16,941) |
| Net working capital | (5,715) | (1,958) | - | (7,673) |
| Other intangible, tangible and right-of-use assets | 16,648 | 4,783 | 1,881 | 23,312 |
| Provision for risks and charges | (1,865) | - | - | (1,865) |
| Other non-current assets and liabilities | (7,875) | (884) | - | (8,759) |
| Non-current assets and liabilities | 6,908 | 3,899 | 1,881 | 12,688 |
| Net invested capital | 1,193 | 1,941 | 1,881 | 5,015 |
| Third Parties Equity | - | - | 14,088 | 14,088 |
| Net financial position | 1,590 | 1,589 | - | 3,179 |
| NET EQUITY ACQUIRED - BOOK VALUE | 2,783 | 3,530 | 15,969 | 22,282 |
| DIFFERENCE TO BE ALLOCATED | 88,931 | 61,947 | 14,096 | 164,974 |
| ALLOCATIONS | ||||
| Trademarks | 11 | 1,308 | - | 1,319 |
| Non-competition agreements | - | 41 | 148 | 189 |
| Customer lists | 28,350 | 11,988 | 4,734 | 45,072 |
| Contract liabilities - Short and long-term | (9,013) | (5,636) | - | (14,649) |
| Deferred tax assets | 1,428 | 2,623 | - | 4,051 |
| Deferred tax liabilities | (4,930) | (3,530) | - | (8,460) |
| ALLOCATIONS | 15,846 | 6,794 | 4,882 | 27,522 |
| GOODWILL | 73,085 | 55,153 | 9,214 | 137,452 |

4. Intangible fixed assets with finite useful life
The following table shows the changes in intangible assets.
| (€ thousands) | Historical cost at 12/31/2023 |
Accumulated amortization and write downs at 12/31/2023 |
Net book value at 12/31/2023 |
Historical cost at 09/30/2024 |
Accumulated amortization and write downs at 09/30/2024 |
Net book value at 09/30/2024 |
|---|---|---|---|---|---|---|
| Software | 289,839 | (171,112) | 118,727 | 322,058 | (203,107) | 118,951 |
| Licenses | 29,731 | (20,618) | 9,113 | 34,572 | (24,418) | 10,154 |
| Non-competition agreements | 19,484 | (14,614) | 4,870 | 22,842 | (17,795) | 5,047 |
| Customer lists | 474,972 | (276,910) | 198,062 | 519,366 | (307,744) | 211,622 |
| Trademarks and concessions | 95,028 | (50,803) | 44,225 | 96,306 | (55,844) | 40,462 |
| Other | 14,056 | (4,197) | 9,859 | 17,172 | (5,215) | 11,957 |
| Fixed assets in progress and advances |
31,733 | - | 31,733 | 30,724 | - | 30,724 |
| Total | 954,843 | (538,254) | 416,589 | 1,043,040 | (614,123) | 428,917 |
| (€ thousands) | Net book value at 12/31/2023 |
Investments | Disposals | Amortization | Business combinations |
Impairment | Other net changes |
Net book value at 09/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Software | 118,727 | 16,458 | - | (32,980) | 110 | (76) | 16,712 | 118,951 |
| Licenses | 9,113 | 2,683 | (10) | (3,815) | 8 | (1) | 2,176 | 10,154 |
| Non-competition agreements |
4,870 | 2,116 | - | (3,270) | 189 | (53) | 1,195 | 5,047 |
| Customer lists | 198,062 | 28 | - | (30,781) | 45,072 | - | (759) | 211,622 |
| Trademarks and concessions |
44,225 | 14 | (10) | (4,994) | 1,311 | - | (84) | 40,462 |
| Other | 9,859 | 272 | 20 | (1,196) | 3,264 | (108) | (154) | 11,957 |
| Fixed assets in progress and advances |
31,733 | 19,017 | (12) | - | 1,096 | 137 | (21,247) | 30,724 |
| Total | 416,589 | 40,588 | (12) | (77,036) | 51,050 | (101) | (2,161) | 428,917 |
The investments in intangible assets (€40,588 thousand) are attributable to the ongoing implementation and standardization of the Group cloud-based ERP system for back-office functions (HR, Procurement, Administration and Finance), the new front office solutions and the AI technologies used to provide customers with a highly personalized experience.
The change in "Business combinations" comprises:
- For €30,028 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
- For €16,140 thousand the temporary allocation of the price paid for acquisitions made in Americas;
- For €4,882 thousand the temporary allocation of the price paid for acquisitions made in APAC.
The item "Other net changes" is explained almost entirely by foreign exchange differences and the reclassification of work in progress completed in the period.

5. Property, plant, and equipment
The following table shows the changes in property, plant, and equipment.
| (€ thousands) | Historical cost at 12/31/2023 |
Accumulated amortization and write downs at 12/31/2023 |
Net book value at 12/31/2023 |
Historical cost at 09/30/2024 |
Accumulated amortization and write downs at 09/30/2024 |
Net book value at 09/30/2024 |
|---|---|---|---|---|---|---|
| Land | 129 | - | 129 | 158 | - | 158 |
| Buildings, constructions and leasehold improvements |
321,929 | (215,933) | 105,996 | 352,587 | (237,624) | 114,963 |
| Plant and machines | 43,102 | (34,441) | 8,661 | 47,274 | (37,888) | 9,386 |
| Industrial and commercial equipment |
91,892 | (71,140) | 20,752 | 96,123 | (75,615) | 20,508 |
| Motor vehicles | 1,259 | (838) | 421 | 1,380 | (741) | 639 |
| Computers and office machinery |
90,415 | (69,133) | 21,282 | 100,006 | (78,959) | 21,047 |
| Furniture and fittings | 136,733 | (100,349) | 36,384 | 150,141 | (110,117) | 40,024 |
| Other tangible fixed assets | 6,686 | (4,228) | 2,458 | 6,709 | (4,765) | 1,944 |
| Fixed assets in progress and advances |
25,433 | - | 25,433 | 34,832 | - | 34,832 |
| Total | 717,578 | (496,062) | 221,516 | 789,210 | (545,709) | 243,501 |
| (€ thousands) | Net book value at 12/31/2023 |
Investments | Disposals | Amortization | Business combinations |
Impairment | Other net changes |
Net book value at 09/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Land | 129 | - | - | - | - | - | 29 | 158 |
| Buildings, constructions and leasehold improvements |
105,996 | 18,679 | (18) | (19,148) | 1,571 | (350) | 8,233 | 114,963 |
| Plant and machines | 8,661 | 1,373 | (2) | (1,925) | 1,221 | (40) | 98 | 9,386 |
| Industrial and commercial equipment |
20,752 | 3,078 | (43) | (4,731) | 462 | (34) | 956 | 20,508 |
| Motor vehicles | 421 | 139 | (103) | (118) | 143 | (17) | 174 | 639 |
| Computers and office machinery |
21,282 | 6,151 | (1) | (9,973) | 1,741 | (14) | 1,861 | 21,047 |
| Furniture and fittings | 36,384 | 7,771 | (64) | (9,258) | 2,009 | (69) | 3,251 | 40,024 |
| Other tangible fixed assets | 2,458 | 122 | 12 | (510) | 60 | - | 46 | 1,944 |
| Fixed assets in progress and advances |
25,433 | 22,192 | (139) | - | 1,880 | (131) | (14,403) | 34,832 |
| Total | 221,516 | 59,261 | (358) | (45,663) | 9,087 | (587) | 245 | 243,501 |
The investments of the reporting period (€59,261 thousand) are mainly related to opening and renewal of shops, and to the purchase of hardware components for IT Group projects implementation.
The change in "Business combinations" comprises:
- For €6,115 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;

- For €1,091 thousand, the temporary allocation of the price paid for acquisitions made in Americas;
- For €1,881 thousand, the temporary allocation of the price paid for acquisitions made in APAC.
"Other net changes" is explained primarily by foreign exchange differences recorded in the reporting period and the reclassification of work in progress completed in the period.
6. Right-of-use assets
Right-of-use assets are reported here below:
| (€ thousands) | Historical cost at 12/31/2023 |
Accumulated amortization and write downs at 12/31/2023 |
Net book value at 12/31/2023 |
Historical cost at 09/30/2024 |
Accumulated amortization and write downs at 09/30/2024 |
Net book value at 09/30/2024 |
|---|---|---|---|---|---|---|
| Stores and offices | 880,210 | (418,590) | 461,620 | 939,894 | (471,703) | 468,191 |
| Motor vehicles | 31,377 | (17,828) | 13,549 | 36,477 | (20,113) | 16,364 |
| Electronic machinery | 4,644 | (1,660) | 2,984 | 4,384 | (1,847) | 2,537 |
| Total | 916,231 | (438,078) | 478,153 | 980,755 | (493,663) | 487,092 |
| Net book | Other | Net book | ||||||
|---|---|---|---|---|---|---|---|---|
| value at | Increase | Decrease | Depreciation | Business combinations |
Impairment | net | value at | |
| (€ thousands) | 12/31/2023 | changes | 09/30/2024 | |||||
| Stores and offices | 461,620 | 101,056 | (12,486) | (89,870) | 9,597 | - | (1,726) | 468,191 |
| Motor vehicles | 13,549 | 10,808 | (2,043) | (6,159) | 150 | - | 59 | 16,364 |
| Electronic machinery | 2,984 | 415 | (3) | (858) | - | - | (1) | 2,537 |
| Total | 478,153 | 112,279 | (14,532) | (96,887) | 9,746 | - | (1,667) | 487,092 |
The increase in right of use assets acquired in the period (€112,279 thousand) is explained by the renewal of existing leases and the network expansion.
The change in "business combinations" comprises:
- for €8,857 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
- for €889 thousand, the temporary allocation of the price paid for acquisitions made in Americas.
"Other changes" refers mainly to foreign exchange differences recorded in the reporting period.

7. Other non-current assets
| (€ thousands) | Balance at 09/30/2024 | Balance at 12/31/2023 | Change |
|---|---|---|---|
| Long-term financial receivables | 6,046 | 12,916 | (6,870) |
| Asset Plans and other restricted amounts | 1,615 | 1,362 | 253 |
| Other non-current assets | 48,263 | 32,557 | 15,706 |
| Total | 55,924 | 46,835 | 9,089 |
Other non-current assets amounted to €55,924 thousand at 30 September 2024 (€46,835 at 31 December 2023).
The increase against the prior year is attributable mainly to the recognition of tax credits stemming from the super bonus discounts in accordance with Art. 119 and 121 of Legislative Decree 34/2020, purchased from a top-tier bank with a nominal value of €69,995 thousand for €65,694 thousand to be repaid as the credits are used. In accordance with the current tax laws, these credits may be used to offset tax payments and other fiscal contributions.
These credits (and the related payments) are recognized at amortized cost and when utilized any remaining difference between the value at amortized cost and the nominal offsetting amount is recognized as financial income.
In the first nine months of 2024, credits used for offsetting amounted to €36,210 thousand and financial income, that include also the effect of actualization, amounted to €2,818 thousand. Financial expenses for discounting payables amounted to €196 thousand.
The statement of financial position at 30 September 2024 includes:
- Tax credits recognized in the Other Receivables line for €13,533 thousand and in the Other Non-Current Assets line for €16,173 thousand;
- Payables recognized in the Other Liabilities line for €17,494 thousand and in the Other Payables line for €18,918 thousand.

8. Share capital and treasury shares
At 30 September 2024 the share capital comprised 226,388,620 ordinary shares with a par value of €0.02 fully paid in and subscribed, unchanged concerning 31 December 2023.
A total of 437,349 of the performance stock grant rights were exercised in the period, as a result of which the company transferred the same number of treasury shares to the beneficiaries.
During the reporting period 720,000 treasury shares have been purchased for a total amount of €20,258 thousand.
During the reporting period, a total of 37,500 shares were transferred as a second deferred payment for Otohub's acquisition in 2019.
A total of 887,299 treasury shares, or 0.392% of the parent's share capital, were held at 30 September 2024.
Information relating to the treasury shares held is shown below:
| No. of treasury | Average purchase price (Euro) | Total amount | ||
|---|---|---|---|---|
| shares | FV of transferred rights (Euro) | (€ thousands) | ||
| Held at 12/31/2023 | 642,148 | 27.245 | 17,495 | |
| Purchases | 720,000 | 28.136 | 20,258 | |
| Transfers due to exercise of performance stock grants | (437,349) | 27.657 | (12,096) | |
| Transfer due to exercise of acquisition's deferred payment | (37,500) | 27.657 | (1,037) | |
| Held at 09/30/2024 | 887,299 | 27.747 | 24,620 |

9. Net financial indebtedness
The Group's net financial indebtedness, including lease liabilities, prepared in accordance with the ESMA guideline 32-382-1138 of 4 March 2021 and CONSOB's Warning Notice n. 5/21 of 29 April 2021, is shown below.
| (€ thousands) | 09/30/2024 | 12/31/2023 | Change |
|---|---|---|---|
| A Cash |
166,775 | 193,148 | (26,373) |
| B Cash equivalent |
- | - | - |
| C Short term investments |
857 | 883 | (26) |
| D Total Cash, Cash Equivalents and Short-Term Investments (A+B+C) |
167,632 | 194,031 | (26,399) |
| Current financial payables (including bonds, but excluding current E portion of medium/long-term debt) |
315,280 | 146,200 | 169,080 |
| - Other financial payables and bank overdrafts | 316,101 | 146,507 | 169,594 |
| - Hedging derivatives | (821) | (307) | (514) |
| F Current portion of medium/long-term financial debt |
318,212 | 294,055 | 24,157 |
| - Financial accruals and deferred income | 7,695 | 6,001 | 1,694 |
| - Payables for business acquisitions | 12,785 | 9,554 | 3,231 |
| - Bank borrowings | 173,508 | 164,978 | 8,530 |
| - Lease Liability – current portion | 124,224 | 113,522 | 10,702 |
| G Current Financial Indebtedness (E+F) |
633,492 | 440,255 | 193,237 |
| H Net Current Financial Indebtedness (G-D) |
465,860 | 246,224 | 219,636 |
| I Non current financial payables |
759,357 | 753,337 | 6,020 |
| - Bank borrowings – Non current portion | 370,917 | 362,199 | 8,718 |
| - Payables for business acquisitions – Non current portion | 5,725 | 7,229 | (1,504) |
| - Lease Liability – Non current portion | 382,715 | 383,909 | (1,194) |
| J Bonds |
350,000 | 350,000 | - |
| - Eurobond 2020-2027 | 350,000 | 350,000 | - |
| K Trade and other non current payables |
- | - | - |
| L Non Current Financial Indebtedness (I+J+K) |
1,109,357 | 1,103,337 | 6,020 |
| M Total Financial Indebtedness (H+L) | 1,575,217 | 1,349,561 | 225,656 |

Excluding lease liabilities (€506,939 thousand at 30 September 2024), net financial indebtedness amounted to €1,068,279 thousand at 30 September 2024, broken down as follows:
| (€ thousands) | Balance at 09/30/2024 | Balance at 12/31/2023 | Change |
|---|---|---|---|
| Cash and Cash Equivalents | 166,775 | 193,148 | (26,373) |
| Short Term Investments | 857 | 883 | (26) |
| Cash, Cash Equivalents and Short Term Investments | 167,632 | 194,031 | (26,399) |
| Current Financial Indebtedness (excluding lease liabilities) |
509,269 | 326,733 | 182,536 |
| Net Current Financial Indebtedness (excluding lease liabilities) |
341,637 | 132,702 | 208,935 |
| Non current Financial Indebtedness (excluding lease liabilities) |
726,642 | 719,428 | 7,214 |
| Total Financial Indebtedness (excluding lease liabilities) | 1,068,279 | 852,130 | 216,149 |
The main transactions occurred during the period are as follows:
- In June 2024 the Group subscribed the last €50 million tranche of the €350 million loan with the European Investment Bank (EIB), of which €300 million was already subscribed, to support innovation and digitalization. This loan increases the available, unutilized irrevocable credit lines which amounted to €675 million at 30 September 2024.
- In September 2024, Crédit Agricole Italia, backed by SACE's Garanzia Futuro, financed for 50 million euros the international roll-out of Amplifon's new store format, aimed at providing consumers with an immersive and completely personalized experience through visual and digital elements integrated into an innovative and sustainable architectural design.
- In the second quarter, as agreed with the lenders and based on the original loan agreements, the ESG KPI relative to the €560 million in ESG-linked lines of credit were updated to reflect the new targets included in the new sustainability plan.
Medium-Long term net financial debt, excluding lease liabilities, amounted to €726,642 thousand at 30 September 2024 (€719,428 thousand at 31 December 2023) substantially in line with 2023: the reclassification as short-term debt of the portions of long-term debt maturing in the next 12 months and of the deferred payments for acquisition was net by new subscriptions.
The short-term portion of net financial debt, excluding lease liabilities, increased by €208,935 thousand, going from €132,702 thousand at 31 December 2023 to €341,637 thousand at 30 September 2024 due primarily to hot money transactions and utilization of short-term credit lines temporary coverage of higher total debt.
More specifically, the short-term portion includes mainly other bank debt linked to hot money transactions and utilization of short-term credit lines (€316,101 thousand), the short-term portions of long-term bank loans (€173,508 thousand), interest payable on other bank

borrowings (€2,320 thousand) and the Eurobond (€2,481 thousand) and lastly, the best estimate of the deferred payments for acquisitions (€12,785 thousand).
After first nine months of 2024, as at 14 October 2024, Amplifon signed with UniCredit and Cassa Depositi e Prestiti (CDP) €200 million credit facility ESG linked, divided as follows:
€100 million from UniCredit to support the Group's development initiatives and €100 million from CDP which co-financed Amplifon's investments in innovation in Italy, as already done by the loan signed with European Investment Bank (EIB) mentioned above.
In this way, a similar reduction in the use of short-term lines was allowed and a reduction of the net short-term debt to approximately €140 million, aligned with the comparative period.
The Group has unutilized, irrevocable lines of credit of €450 million which, in addition to the unutilized portion of the EIB loan of €225 million, the €69 million in available uncommitted credit lines and the cash generation expected for 2024, ensure enough liquidity to satisfy current obligations and support business needs.
Bank loans, and the Eurobond 2020-2027 are included in the statement of financial position as follows:
a. under the item "medium/long-term financial liabilities":
| (€ thousands) | Balance at 09/30/2024 |
|---|---|
| Eurobond 2020-2027 | 350,000 |
| Loan with the European Investment Bank | 125,000 |
| Other medium/long-term debt | 245,917 |
| Fees on Eurobond 2020-2027 and bank loans | (1,168) |
| Medium/long-term financial liabilities | 719,749 |
b. under the item "financial payables (current)":
| (€ thousands) | Balance at 09/30/2024 |
|---|---|
| Bank overdraft and other short-term debt (including current portion of other long-term debt) | 489,452 |
| Other financial payables | 7,695 |
| Fees on bank loans | (953) |
| Short-term financial liabilities | 496,194 |
All the other items in the net financial position table can be easily referred to in the financial consolidated statements.

10. Financial liabilities
The financial liabilities breakdown is as follows:
| (€ thousands) | Balance at 09/30/2024 |
Balance at 12/31/2023 |
Change |
|---|---|---|---|
| Eurobond 2020-2027 | 350,000 | 350,000 | - |
| Loan with European Bank of Investments | 125,000 | 75,000 | 50,000 |
| Other medium long-term bank loans | 245,917 | 287,199 | (41,282) |
| Fees on Eurobond 2020-2027 and bank loans | (1,168) | (1,932) | 764 |
| Total long-term financial liabilities | 719,749 | 710,267 | 9,482 |
| Short term debt | 496,194 | 316,413 | 179,781 |
| - of which debts for account overdrafts and other short-term liabilities | 315,128 | 146,299 | 168,829 |
| - of which current portion of short-term bank loans | 173,508 | 164,978 | 8,530 |
| - of which for bank loans | (953) | (1,075) | 121 |
| Total short-term financial liabilities | 496,194 | 316,413 | 179,781 |
| Total financial liabilities | 1,215,943 | 1,026,679 | 189,263 |
The main financial liabilities are detailed below.
- Eurobond 2020-2027
This is a €350,000 thousand 7-year non-convertible bond with a fixed annual coupon of 1.125% that is listed on the Luxembourg Stock Exchange's unregulated market.
| Issue Date | Debtor | Maturity | Nominal value (€/000) |
Nominal interest rate (*) |
Euro interest rate after hedging |
|---|---|---|---|---|---|
| 02/13/2020 | Amplifon S.p.A. | 02/13/2027 | 350,000 | 1.125% | N/A |
| Total in Euro | 350,000 |
(*) The nominal interest rate is equal to the mid swap plus a spread.

- Bank loans
These are the main bilateral and pooled loans which are detailed below:
| Issue Date | Debtor | Type | Maturity | Nominal value (€/000) |
Outstan ding debt (€/000) |
Nominal interest rate (*) |
Hedged nominal amount (**) |
Interest rate after hedging (**) |
|
|---|---|---|---|---|---|---|---|---|---|
| Loan EIB | 12/15/23 | Amplifon S.p.A. | Amortizing | 12/15/32 | 125,000 | 125,000 | (***) | ||
| Other bank | 04/06/20 | Amplifon S.p.A. | Amortizing | 04/06/25 | 50,000 | 14,285 | 5.141% | 14,285 | 0.880% |
| 04/28/20 | Amplifon S.p.A. | Amortizing | 04/28/25 | 50,000 | 37,500 | 4.855% | |||
| 04/23/20 | Amplifon S.p.A. | Amortizing | 06/30/25 | 35,000 | 16,625 | 4.572% | 16,625 | 0.785% | |
| 08/03/20 | Amplifon S.p.A. | Amortizing | 06/30/25 | 10,000 | 1,534 | 4.850% | |||
| 12/23/21 | Amplifon S.p.A. | Amortizing | 12/23/26 | 210,000 | 159,600 | 4.472% | 159,600 | 0.963% | |
| loans | 04/07/20 | Amplifon S.p.A. | Amortizing | 04/07/25 | 150,000 | 60,000 | 4.884% | 40,000 | 1.05% |
| 04/29/20 | Amplifon S.p.A. | Amortizing | 04/29/25 | 78,000 | 19,500 | 5.325% | 13,650 | 1.414% | |
| 12/29/23 | Amplifon S.p.A. | RCF (no cleandown) |
09/30/26 | 60,000 | 60,000 | 4.900% | |||
| 09/30/24 | Amplifon S.p.A. | Amortizing | 09/30/26 | 50,000 | 50,000 | 4.319% | 50,000 | 3.226% | |
| Total | 818,000 | 544,044 | 294,160 |
(*) The nominal interest rate comprises the benchmark rate (Euribor) plus the applicable spread.
(**) An Interest Rate Swap was used to hedge these loans against interest rate risk at the IRS rate plus a spread.
(***) The rate for €75 million granted in 2023 is equal to 3.653% until 12/15/2027. It will subsequently be adjusted to reflect current market conditions and the Group may choose either a fixed or a floating rate.
For the €50 million granted in 2024, the rate applied is 3.902% and it's fixed to the end of loan.
Group's loans, bonds, and revolving credit lines are subject to the following financial covenants:
- the net financial indebtedness, excluding lease liabilities, to Group net equity (Net Worth Ratio) must not exceed 1.65;
- the Leverage Ratio, calculated as the ratio of net financial debt, excluding lease liabilities, to EBITDA recorded in the last four quarters (determined excluding the fair value of the stock-based payments, based solely on recurring business, and restated if the Group's structure should change significantly), must not exceed 2.85;
- the Interest Cover, calculated as the ratio of EBITDA (restated like the EBITDA used to calculate the leverage ratio) recorded in the last four quarters and the net interest owed in the same four quarters, must not exceed 4.9.
Typically, in the event of relevant acquisitions, the first two ratios may be increased to 2.20 and 3.26, respectively, for a period of not more than 12 months, twice over the life of the respective loans.

The trigger events for these covenants and the "spikes" relative to significant acquisitions (i.e. increase in benchmark index for maximum 12 months and twice along the duration of the financial liability) are summarized below:
| Primary Credit Facility Agreement | Leverage Ratio | Net Worth Ratio | Interest Cover | Spike |
|---|---|---|---|---|
| - Medium/long-term bilateral loans with top-tier banking institutions of €99 million. - Irrevocable credit lines with top-tier |
≤ 2.85 | ≤ 1.65 | - | ≤ 3.26 (Leverage Ratio) ≤ 2.20 (Net Worth |
| banking institutions of €110 million. | Ratio) | |||
| - €14.3 million bank loan expiring in 2025; |
≤ 2.85 | - | > 4.90 | ≤ 3.26 (Leverage Ratio) |
| -Medium/long-term bilateral loans with top-tier banking institutions of €96.1 million; |
≤ 2.85 | ≤ 1.65 | > 4.90 | ≤ 3.26 (Leverage Ratio) |
| -Irrevocable lines of credit with premier banks amounted to €40 million. |
≤ 2.20 (Net Worth Ratio) |
The loan negotiated at the end of 2021, which replaced the syndicated loan used for the GAES acquisition with a residual amount of €159.6 million, the new €300 million revolving facility negotiated at the end of May 2023, the loan of €50 million negotiated at the end of September 2024 (which are allsustainability-linked) and the €350 million loan, to date used for €125 million, granted by the European Investment Bank are not subject to covenants. However, the financial covenants on the other credit facilities will also be extended to these lenders as a result of a most favoured clause.
The three financial covenants and the relative spikes, shown in the table above, are, therefore, applied to these credit lines to the extent that they are also applied to the other facilities.
As at 30 September 2024 these ratios were as follows
| Value as at | |
|---|---|
| 09/30/2024 | |
| Net financial indebtedness excluding lease liabilities/Group net equity (Net Worth Ratio) | 0.96 |
| Net financial position excluding lease liabilities/EBITDA for the last four quarters (Leverage Ratio) | 1.78 |
| EBITDA for the last 4 quarters/Net financial expenses (Interest Cover) | 17.20 |

The above-mentioned ratios were determined based on an EBITDA which was restated and normalized, in order to reflect the main changes.
| (€ thousands) | Value as at 09/30/2024 |
|---|---|
| Group EBITDA first nine months 2024 | 407,813 |
| EBITDA October-December 2023 | 154,263 |
| Fair value of stock grant assignment | 18,893 |
| EBITDA normalized (from acquisitions and disposals) | 11,027 |
| Acquisitions and non-recurring costs | 6,611 |
| EBITDA for the covenant calculation | 598,607 |
The same agreements are also subject to other covenants applied in current international practice which limit the ability to issue guarantees and complete sales and lease backs, as well as extraordinary transactions involving the sale of assets.
11. Provision for risks and charges
Provisions for risks and charges amounted to €23,959 thousand, slightly higher than the €20,647 thousand recorded at 31 December 2023.
The provisions for risks at 30 September 2024 are detailed below:
| (€ thousands) | Balance at 09/30/2024 | Balance at 12/31/2023 | Change |
|---|---|---|---|
| Product warranty provision | 1,268 | 1,191 | 77 |
| Provision on contract risks | 3,763 | 3,420 | 343 |
| Agents' leaving indemnities | 14,209 | 13,092 | 1,117 |
| Other reserves for risks and charges | 2,571 | 1,676 | 895 |
| Total Long-term provision for risks and charges | 21,811 | 19,379 | 2,432 |
| Product warranty provision | 197 | 205 | (8) |
| Other reserves for risks and charges | 1,951 | 1,063 | 888 |
| Total Short-term provision for risks and charges | 2,148 | 1,268 | 880 |
| Total provision for risks and charges | 23,959 | 20,647 | 3,312 |

12. Lease liabilities
The lease liabilities stem from long-term leases and rental agreements. These liabilities are equal to the present value of future installments payable over the lease term.
The finance lease liabilities are shown in the statement of financial position as follows:
| (€ thousands) | Balance at 09/30/2024 |
Balance at 12/31/2023 |
Change |
|---|---|---|---|
| Short term lease liabilities | 124,224 | 113,523 | 10,701 |
| Long term lease liabilities | 382,715 | 383,909 | (1,195) |
| Total lease liabilities | 506,939 | 497,431 | 9,507 |
During the reporting period, following costs have been booked in profit and loss:
| (€ thousands) | First Nine month of 2024 |
|---|---|
| Interest charges on leased assets | (13,786) |
| Right-of-use depreciation | (96,887) |
| Costs for short-term leases and leases for low value assets | (14,856) |
13. Revenues from sales and services
| (€ thousands) | First Nine month of 2024 |
First nine month of 2023 |
Change |
|---|---|---|---|
| Revenues from sale of products | 1,521,997 | 1,430,065 | 91,932 |
| Revenues from services | 222,836 | 215,000 | 7,836 |
| Total revenues from sales and services | 1,744,833 | 1,645,065 | 99,768 |
| Goods and services provided at a point in time | 1,521,997 | 1,430,065 | 91,932 |
| Goods and services provided over time | 222,836 | 215,000 | 7,836 |
| Total revenues from sales and services | 1,744,833 | 1,645,065 | 99,768 |
Consolidated revenues from sales and services amounted to €1,744,833 thousand in the first nine months of 2024, an increase of €99,768 thousand (+6.1%) compared to the same period of the prior year.
The increase compared to the first nine month of 2023 is attributable for €71,177 thousand to organic growth (+4.3%), acquisitions for €59,903 thousand (+3.7%) and negative exchange differences for €31,312 thousand (-1.9%).
Revenues of the Argentine subsidiary were impacted by the inflation accounting used pursuant to IAS 29 (Inflation Accounting), which had a positive impact on the Group's organic growth and a negative impact on the exchange effect of 0.3%, respectively.

14. Operating costs, depreciation and impairment, financial income-expenses and taxes
Operating costs amounted to €1,342,180 thousand in the first nine months of 2024 (€1,277,988 thousand in the first nine months of 2023), an increase of €64,192 thousand (+5%).
"Amortization, depreciation and impairment" amounted to €220,274 thousand at 30 September 2024 higher than the €192,916 thousand recorded in the first nine months of 2023.
"Financial income, expenses and value adjustments to financial assets" came to €43,597 thousand in the first nine months of 2024 (€36,893 thousand in the first nine months of 2023).
The change in the reporting period of €6,704 thousand is explained by the increase in interest payable linked to both higher average debt (that includes also the IFRS 16 accounting of higher lease liability stemming from the network expansion) as well as increased interest rates compared to first nine month of 2023 were partially offset by lower exchange differences and financial income stemming from the recognition of tax credits for the deferred payment of acquisitions contained in and regulated by Articles 119 and 121 of Legislative Decree n. 34/2020 ("Decreto Rilancio").
Current and deferred tax amounted to €39,627 thousand in the first nine months of 2024, €292 thousand lower than in the first nine months of 2023 (€39,335 thousand).
The tax rate was 27.5% in the reporting period versus 27.6% at 30 September 2023.

15. Performance Stock Grant
On May 7, 2024, the Board of Directors of Amplifon S.p.A., following the recommendation of the Remuneration and Nomination Committee, pursuant to Article 84 bis, paragraph 5 of Consob Regulation no. 11971/99 and subsequent amendments, resolved to allocate 551,800 target rights at the end of a 3-year vesting period as the first tranche of the Stock Grant Cycle 2024- 2026.
The fair value per unit of these granted stock grants during the reported period is €31.46.
| The assumptions used in determining the fair value are as follows: |
|---|
| Valuation Model | Binomial Tree (Cox-Ross-Rubinstein method) | |
|---|---|---|
| Price at grant date | €32.26 | |
| Threshold | - € | |
| Exercise price | 0.00 | |
| Volatility (3 years) | 33.51% | |
| Risk-free interest rate | 3.038% | |
| Maturiy (in years) | 3 | |
| Maturity date | March 31, 2027 | |
| Expected Dividend Yield | 0.87% |
The figurative cost of this grant cycle recorded in the income statement as of September 30, 2024 amounts to €1,265 thousand.
Sustainable value sharing plan 2022-2027
The Board of Directors of Amplifon S.p.A., following the recommendation of the Remuneration and Nomination Committee, pursuant to Article 84 bis, paragraph 5 of Consob Regulation no. 11971/99, has resolved to allocate a maximum of 109,200 rights under the Sustainable Value Sharing Plan 2022-2027, reserved for the CEO and Key Executives of the Group (Beneficiaries), as described in the Information Document approved by the Shareholders' Meeting on April 24, 2024.
The scheme is a composite incentive tool that operates through two distinct phases, of which the second phase is contingent and dependent on the progress of the first phase (referred to as "Phase A" and "Phase B," respectively). Phase A: Starting from the 2024 fiscal year, the Target MBO achieved and hypothetically due to the Beneficiaries under the applicable MBO Plan for the previous fiscal year (including the one related to 2023) will not be paid out. Instead, the Beneficiaries will receive a certain number of rights (the "Co-invested Rights") that will entitle them to receive shares at the end of the vesting period of Phase B described below, or earlier if Phase B does not vest.
Phase B: If, in a given fiscal year, the Beneficiaries receive Co-invested Rights under the mechanism described above, they will participate in an additional and separate incentive tool based on financial instruments, wherein the Company allocates additional rights to them, equal

in number to the Co-invested Rights. These rights (the "Matched Rights") will entitle the Beneficiaries to receive shares provided that certain performance targets linked to value generation and sustainable success of the Group are met by the end of the vesting period.
Regarding the Sustainable Value Sharing Plan 2022-2027 reserved for the CEO and Key Executives of the Group, the conversion of the accrued MBO led to the allocation of 54,600 Coinvested Rights and 54,600 Matched Rights.
The assumptions used in determining the fair value are as follows:
| PHASE A | PHASE B | |
|---|---|---|
| Valuation model | Binomial Tree (Cox-Ross-Rubinstein method) | Binomial Tree (Cox-Ross-Rubinstein method) |
| FV | €31.46 | €24.83 |
| KPI | - | ESG/TSR |
| Exercise price | 0.00 | 0.00 |
| Volatility (3 years) | 33.51% | 33.51% |
| Risk-free interest rate | 3.038% | 3.038% |
| Maturity (in years) | 3 | 3 |
| Maturity date | March 31, 2027 | March 31, 2027 |
| Expected dividend yield | 0.87% | 0.87% |
16. Non-recurring significant events
The first nine months of 2024 were impacted by the following non-recurring items:
| (€ thousands) | First nine months of 2024 |
First nine month of 2023 |
|
|---|---|---|---|
| Operating costs | Costs incurred to define and implement amendments to the Articles of Association including the enhanced voting rights |
(1,678) | - |
| Costs related to second phase of the GAES integration | (1,478) | (1,433) | |
| Notional cost of the Amplifon shares assigned by the shareholder Ampliter to the CEO |
(1,138) | (11,614) | |
| Costs related to Bay Audio integration | (127) | (174) | |
| EBITDA | (4,421) | (13,221) | |
| Profit (loss) before tax | (4,421) | (13,221) | |
| Impact of the above items on the tax burden for the period | 1,223 | 3,844 | |
| Total net profit (loss) | (3,198) | (9,377) |

17. Earnings (loss) per share
Basic Earnings (loss) per share
Basic earnings (loss) per share is obtained by dividing the net profit for the year attributable to the ordinary shareholders of the parent company by the weighted average number of shares outstanding in the period, considering purchases and disposals of own shares as cancellations and issues of shares.
Earnings per share are determined as follows:
| Earnings per share | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| Net profit (loss) attribuable to ordinary shareholders (€ thousand) | 104,181 | 103,438 |
| Average number of shares outstanding in the period | 225,934,134 | 224,054,021 |
| Average number per share (€ per share) | 0.46111 | 0.46167 |
Diluted earnings (loss) per share
Diluted earnings (loss) per share is obtained by dividing the net profit for the period attributable to the ordinary shareholders of the parent by the weighted average number of shares outstanding during the year adjusted by the diluting effects of potential shares. In the calculation of shares outstanding, purchases and sales of treasury shares are considered as cancellation or issue of shares.
The potential ordinary share categories refer to the possible conversion of Group employees' stock options and stock grants' attribution. The computation of the average number of outstanding potential shares is based on the average fair value of shares for the period; stock options and stock grants are excluded from the calculation since they have anti-diluting effects.
| Weighted average diluted number of shares outstanding | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| Average number of shares outstanding in the period | 225,934,134 | 224,054,021 |
| Weighted average of potential and diluting ordinary shares | 1,705,974 | 1,766,662 |
| Weighted average of shares potentially subject to options in the period | 227,640,108 | 225,820,683 |
The diluted earnings per share were determined as follows:
| Diluted earnings per share | First nine months 2024 |
First nine months 2023 |
|---|---|---|
| Net profit attributable to ordinary shareholders (€ thousand) | 104,181 | 103,438 |
| Average number of shares outstanding in the period | 227,640,108 | 225,820,683 |
| Average diluted earnings per share (€) | 0.45766 | 0.45805 |

18. Transactions with parents and other related parties
The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.04% of share capital and 59.09% of voting rights), held for 100.0% by Amplifin S.r.l., which is owned for 100% by Susan Carol Holland.
The transactions with related parties, including intercompany transactions, do not qualify as atypical or unusual, and fall within the Group's normal course of business and are conducted at arm's-length as dictated by the nature of the goods and services provided.
The following table details transactions with related parties.
| 09/30/2024 | First Nine months 2024 | ||||||
|---|---|---|---|---|---|---|---|
| (€ thousand) | Trade receivables |
Trade payables |
Other receivables |
Revenues for sales and services |
Operating (costs)/revenues |
Interest income and expense |
|
| Amplifin S.r.l. | 8 | (5) | - | - | 15 | - | |
| Total – Parent company | 8 | (5) | - | - | 15 | - | |
| Comfoor BV (The Netherlands) | 38 | 2,036 | - | 40 | (1,151) | - | |
| Ruti Levinson Institute Ltd (Israel) | 20 | - | - | - | - | - | |
| Afik - Test Diagnosis & Hearing Aids Ltd (Israel) |
23 | - | - | - | - | - | |
| Total – Other related parties | 81 | 2,036 | 40 | (1,151) | - | ||
| Total related parties | 89 | 2,031 | 40 | (1,136) | - | ||
| Total as per financial statements | 220,673 | 316,965 | 136,610 | 1,744,833 | (1,342,181) | (26,190) | |
| % of financial statements total | 0.04% | 0.64% | 0.00% | 0.00% | 0.08% | 0.00% |
The trade and other receivables refer primarily to:
- the recovery of maintenance costs and building fees from Amplifin S.r.l.;
- the receivables due by Amplifin S.r.l. for the renovation of the headquarters based on modern and efficient standards for the use of workspaces;
- the trade receivables due by associates (mainly in Israel) who act as resellers and to which the Group supplies hearing aids.
The trade payables and operating costs refer primarily to commercial transactions with Comfoor BV, a joint venture from which hearing protection devices are purchased and then distributed in Group stores.
Services costs charged to Amplifon S.p.A. as a result of the contracts with Amplifin S.r.l. include for €1,698 thousand the rental fees related to the lease agreement concluded for the property, located in Milan, via Ripamonti n. 133, legal and administrative headquarters of Amplifon S.p.A.
The lease costsfor the Milan headquarters (leased to Amplifon by the parent company Amplifin) are no longer shown as operating costs and trade payables but are recognized under right-of-

use depreciation for €1,367 thousand, interest on leases for €348 thousand, lease liabilities of € 10,728 thousand and right-of-use asset of €9,571 thousand.
19. Contingent liabilities
Currently the Group is not exposed to any particular risks, uncertainties or legal disputes in excess of the provisions already made in the financial statements, shown in Note 11. The usual tax audits are currently underway and no findings of note have been reported so far and the Group is, at any rate, confident in the adequacy of the measures implemented.
20. Financial risk management
As this condensed consolidated interim financial report does not include all the additional information that is mandatorily included in the Annual Report relating to the management of financial risk, for a detailed analysis of financial risk management reference should be made to the Group's 2023 Annual Report.

21. Translation of foreign companies' financial statements
The exchange rates used to translate non-Euro zone companies' financial statements are as follows:
| 30 September 2024 | 2023 | 30 September 2023 | ||||
|---|---|---|---|---|---|---|
| Average exchange rate | As at 30 September |
As at 31 December |
Average exchange rate |
As at 30 September |
||
| Panamanian balboa | 1.0871 | 1.1196 | 1.1050 | 1.0833 | 1.0594 | |
| Australian dollar | 1.6415 | 1.6166 | 1.6263 | 1.6205 | 1.6339 | |
| Canadian dollar | 1.4787 | 1.5133 | 1.4642 | 1.4576 | 1.4227 | |
| New Zealand dollar | 1.7832 | 1.7616 | 1.7504 | 1.7547 | 1.7575 | |
| Singapore dollar | 1.4539 | 1.4342 | 1.4591 | 1.4523 | 1.4443 | |
| US dollar | 1.0871 | 1.1196 | 1.1050 | 1.0833 | 1.0594 | |
| Hungarian florin | 391.2500 | 396.8800 | 382.80 | 381.7600 | 389.5000 | |
| Swiss franc | 0.9581 | 0.9439 | 0.9260 | 0.9774 | 0.9669 | |
| Egyptian lira | 47.7407 | 54.1396 | 34.1589 | 33.1383 | 32.7298 | |
| New Israeli shekel | 4.0239 | 4.1491 | 3.9993 | 3.9474 | 4.0472 | |
| Argentine peso (*) | 1082.8093 | 1082.8093 | 892.9239 | 370.8149 | 370.8149 | |
| Chilean peso | 1018.4400 | 1006.9300 | 977.07 | 890.0800 | 959.8000 | |
| Colombian peso | 4328.4100 | 4676.6100 | 4267.52 | 4772.1400 | 4312.3900 | |
| Mexican peso | 19.2951 | 21.9842 | 18.7231 | 19.2804 | 18.5030 | |
| Chinese renminbi | 7.8248 | 7.8511 | 7.8509 | 5.4245 | 5.3065 | |
| Indian rupee | 90.6822 | 93.8130 | 91.9045 | 7.6235 | 7.7352 | |
| British pound | 0.8514 | 0.8354 | 0.8691 | 89.2314 | 88.0165 | |
| Polish zloty | 4.3053 | 4.2788 | 4.3395 | 0.8707 | 0.8646 | |
| Uruguayan peso | 42.8203 | 46.6281 | N.A. | N.A. | N.A. |
(*) Argentina is a highly inflationary country. As requested by IAS 29, profit and loss items have been converted at the closing exchange rate.
The average Argentine peso exchange rate as at 30 September 2024 is 964.6541 and 253.2357 at 30 September 2023.

22. Segment reporting
In accordance with IFRS 8 "Operating Segments", the schedules related to each operating segment are shown below.
The Amplifon Group's business (distribution and customization of hearing solutions) is organized into three specific geographical areas which comprise the Group's operating segments: Europe, Middle-East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Spain, Portugal, Switzerland, Belgium, Hungary, Egypt, Poland, and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama, Mexico and Uruguay) and Asia-Pacific (Australia, New Zealand, India, and China).
The Group also operates via centralized Corporate functions (Corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8.
These areas of responsibility, which coincide with the geographical areas (the Corporate functions are recognized under EMEA), represent the organizational structure used by management to run the Group's operations. The reports periodically analyzed by the Chief Executive Officer and Top Management are divided up accordingly, by geographical area.
Performances are monitored and measured for each operating segment/geographical area, through operating profit including amortization and depreciation (EBIT), along with the portion of the results of equity investments in associated companies valued by using the equity method. Financial expenses are not monitored insofar as they are based on corporate decisions regarding the financing of each region (own funds versus borrowings) and, consequently, neither are taxes. Items in the statement of financial position are analyzed by the geographical area without being separated from the Corporate functions which remain part of EMEA. All the information relating to the income statement and the statement of financial position is determined using the same criteria and accounting standards used to prepare the consolidated financial statements.

Statement of Financial Position as at September 30th, 2024 (*)
| (€ thousands) | EMEA | AMERICAS | APAC | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-current assets | |||||
| Goodwill | 1,028,294 | 294,503 | 619,534 | - | 1,942,331 |
| Intangible fixed assets with finite useful life | 306,542 | 60,550 | 61,825 | - | 428,917 |
| Property, plant, and equipment | 163,879 | 37,478 | 42,144 | - | 243,501 |
| Right-of-use assets | 377,716 | 45,522 | 63,854 | - | 487,092 |
| Equity-accounted investments | 2,724 | - | - | - | 2,724 |
| Hedging instruments | 5,753 | - | - | - | 5,753 |
| Deferred tax assets | 59,258 | 11,040 | 12,458 | - | 82,756 |
| Deferred contract costs | 10,313 | 1,256 | 16 | - | 11,585 |
| Other assets | 46,141 | 7,780 | 2,003 | - | 55,924 |
| Total non-current assets | 3,260,583 | ||||
| Current assets | |||||
| Inventories | 69,038 | 14,347 | 9,483 | - | 92,868 |
| Receivables | 328,601 | 84,345 | 28,223 | (83,886) | 357,283 |
| Deferred contract costs | 6,036 | 950 | 170 | - | 7,156 |
| Hedging instruments | 2,040 | - | - | - | 2,040 |
| Other financial assets | 875 | ||||
| Cash and cash equivalents | 166,775 | ||||
| Total current assets | 626,997 | ||||
| TOTAL ASSETS | 3,887,580 | ||||
| LIABILITIES | |||||
| Net Equity | 1,118,265 | ||||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | 719,749 | ||||
| Lease liabilities | 304,773 | 37,164 | 40,778 | - | 382,715 |
| Provisions for risks and charges | 19,825 | 1,139 | 847 | - | 21,811 |
| Liabilities for employees' benefits | 12,037 | 5 | 776 | - | 12,818 |
| Deferred tax liabilities | 66,202 | 22,272 | 14,017 | - | 102,491 |
| Payables for business acquisitions | 2,172 | 3,553 | - | - | 5,725 |
| Contract liabilities | 146,343 | 14,151 | 2,418 | - | 162,912 |
| Other long-term liabilities | 39,502 | 449 | 47 | - | 39,998 |
| Total non-current liabilities | 1,448,219 | ||||
| Current liabilities | |||||
| Trade payables | 282,495 | 75,884 | 42,277 | (83,691) | 316,965 |
| Payables for business acquisitions | 6,318 | 6,193 | 274 | - | 12,785 |
| Contract liabilities | 95,264 | 16,626 | 8,064 | - | 119,954 |
| Other payables and tax payables | 186,007 | 26,632 | 31,865 | (195) | 244,309 |
| Hedging instruments | 341 | - | - | - | 341 |
| Provisions for risks and charges | 1,544 | 604 | - | - | 2,148 |
| Liabilities for employees' benefits | 1,097 | 433 | 2,646 | - | 4,176 |
| Short-term financial liabilities | 496,194 | ||||
| Lease liabilities | 88,718 | 12,326 | 23,180 | - | 124,224 |
| Total current liabilities | 1,321,096 | ||||
| Total liabilities | 3,887,580 |
(*) The items in the statement of financial position are analyzed by the CEO and Top Management by geographic area without being separated from the Corporate functions which are included in EMEA.

Statement of Financial Position as at December 31st, 2023 (*)
| (€ thousands) | EMEA | AMERICAS | APAC | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-current assets | |||||
| Goodwill | 955,383 | 237,178 | 607,013 | - | 1,799,574 |
| Intangible fixed assets with finite useful life | 300,231 | 50,646 | 65,712 | - | 416,589 |
| Property, plant, and equipment | 148,081 | 29,929 | 43,506 | - | 221,516 |
| Right-of-use assets | 373,293 | 44,949 | 59,911 | - | 478,153 |
| Equity-accounted investments | 2,444 | - | - | - | 2,444 |
| Hedging instruments | 12,933 | - | - | - | 12,933 |
| Deferred tax assets | 63,112 | 7,307 | 12,282 | - | 82,701 |
| Deferred contract costs | 9,988 | 1,257 | 30 | - | 11,275 |
| Other assets | 30,896 | 14,025 | 1,914 | - | 46,835 |
| Total non-current assets | 3,072,020 | ||||
| Current assets | |||||
| Inventories | 70,314 | 8,729 | 9,277 | - | 88,320 |
| Receivables | 311,674 | 70,510 | 34,213 | (84,960) | 331,437 |
| Deferred contract costs | 5,776 | 914 | 150 | - | 6,840 |
| Hedging instruments | 549 | - | - | - | 549 |
| Other financial assets | 901 | ||||
| Cash and cash equivalents | 193,148 | ||||
| Total current assets | 621,195 | ||||
| TOTAL ASSETS | 3,693,215 | ||||
| LIABILITIES | |||||
| Net Equity | 1,101,678 | ||||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | 710,267 | ||||
| Lease liabilities | 305,426 | 37,599 | 40,884 | - | 383,909 |
| Provisions for risks and charges | 17,668 | 896 | 815 | - | 19,379 |
| Liabilities for employees' benefits | 12,119 | 143 | 701 | - | 12,963 |
| Deferred tax liabilities | 62,023 | 19,725 | 16,703 | - | 98,451 |
| Payables for business acquisitions | 5,088 | 2,141 | - | - | 7,229 |
| Contract liabilities | 139,036 | 12,341 | 2,339 | - | 153,716 |
| Other long-term liabilities | 21,773 | 511 | 4,095 | - | 26,379 |
| Total non-current liabilities | 1,412,293 | ||||
| Current liabilities | |||||
| Trade payables | 327,768 | 70,879 | 45,073 | (84,765) | 358,955 |
| Payables for business acquisitions | 4,283 | 4,889 | 382 | - | 9,554 |
| Contract liabilities | 96,941 | 15,279 | 7,823 | - | 120,043 |
| Other payables and tax payables | 195,847 | 28,063 | 31,819 | (195) | 255,534 |
| Hedging instruments | 242 | - | - | - | 242 |
| Provisions for risks and charges | 586 | 682 | - | - | 1,268 |
| Liabilities for employees' benefits | 1,069 | 381 | 2,263 | - | 3,713 |
| Short-term financial liabilities | 316,413 | ||||
| Lease liabilities | 81,704 | 10,834 | 20,984 | - | 113,522 |
| Total current liabilities | 1,179,244 | ||||
| Total liabilities | 3,693,215 |
(*) The items in the statement of financial position are analyzed by the CEO and Top Management by geographic area without being separated from the Corporate functions which are included in EMEA.

Income statement - September 30, 2024 (*)
| (€ thousands) | EMEA | AMERICAS | APAC | CORPORATE | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|---|
| Revenues from sales and services | 1,101,713 | 366,417 | 276,466 | 237 | - | 1,744,833 |
| Operating costs | (797,387) | (277,727) | (203,190) | (63,876) | - | (1,342,180) |
| Other income and costs | 3,070 | 2,312 | (326) | 104 | - | 5,160 |
| Gross operating profit by segment (EBITDA) |
307,396 | 91,002 | 72,950 | (63,535) | - | 407,813 |
| Amortization, depreciation and impairment |
||||||
| Intangible assets amortization | (35,450) | (10,658) | (11,726) | (19,202) | - | (77,036) |
| Property, plant, and equipment depreciation |
(26,905) | (5,832) | (11,763) | (1,163) | - | (45,663) |
| Right-of-use depreciation | (62,504) | (10,528) | (22,079) | (1,776) | - | (96,887) |
| Impairment losses and reversals of non current assets |
(648) | - | (40) | - | - | (688) |
| (125,507) | (27,018) | (45,608) | (22,141) | - | (220,274) | |
| Operating result by segment | 181,889 | 63,984 | 27,342 | (85,676) | - | 187,539 |
| Financial income, expenses and value adjustments to financial assets Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
283 | - | - | - | - | 283 |
| Interest income and expenses | (26,190) | |||||
| Interest expenses on lease liabilities | (13,786) | |||||
| Other financial income and expenses | (1,658) | |||||
| Exchange gains and losses, and inflation accounting |
(2,759) | |||||
| Gain (loss) on assets accounted at fair value |
513 | |||||
| (43,597) | ||||||
| Net profit (loss) before tax | 143,942 | |||||
| Current and deferred income tax | ||||||
| Current income tax | (38,443) | |||||
| Deferred tax | (1,184) | |||||
| (39,627) | ||||||
| Net profit (loss) | 104,315 | |||||
| Net profit (loss) attributable to Minority interests |
134 | |||||
| Net profit (loss) attributable to the Group | 104,181 |
(*) The figures of the operating segments are net of the intercompany eliminations.

Income statement - September 30, 2023 (*)
| (€ thousands) | EMEA | AMERICAS | APAC | CORPORATE | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|---|
| Revenues from sales and services | 1,067,232 | 321,984 | 255,511 | 338 | - | 1,645,065 |
| Operating costs (**) | (771,871) | (239,671) | (189,209) | (77,237) | - | (1,277,988) |
| Other income and costs (**) | 3,473 | 1,636 | (10) | 409 | - | 5,508 |
| Gross operating profit by segment (EBITDA) |
298,834 | 83,949 | 66,292 | (76,490) | - | 372,585 |
| Amortization, depreciation and impairment |
||||||
| Intangible assets amortization | (30,732) | (7,322) | (10,948) | (16,317) | - | (65,319) |
| Property, plant, and equipment depreciation |
(24,581) | (4,727) | (8,110) | (2,068) | - | (39,486) |
| Right-of-use depreciation | (58,042) | (8,675) | (19,491) | (1,700) | - | (87,908) |
| Impairment losses and reversals of non current assets |
(189) | (5) | (9) | - | - | (203) |
| (113,544) | (20,729) | (38,558) | (20,085) | - | (192,916) | |
| Operating result by segment | 185,290 | 63,220 | 27,734 | (96,575) | - | 179,669 |
| adjustments to financial assets Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
210 | - | - | - | - | 210 |
| Interest income and expenses | (19,036) | |||||
| Interest expenses on lease liabilities | (10,846) | |||||
| Other financial income and expenses | (3,528) | |||||
| Exchange gains and losses, and inflation accounting |
(4,438) | |||||
| Gain (loss) on assets accounted at fair value |
745 | |||||
| (36,893) | ||||||
| Net profit (loss) before tax | 142,776 | |||||
| Current and deferred income tax | ||||||
| Current income tax | (46,218) | |||||
| Deferred tax | 6,883 | |||||
| (39,335) | ||||||
| Net profit (loss) | 103,441 | |||||
| Net profit (loss) attributable to Minority interests |
3 | |||||
| Net profit (loss) attributable to the Group | 103,438 |
(*) The figures of the operating segments are net of the intercompany eliminations.
(**) It is specified that, on the comparative period, reclassifications between operating costs and other income and costs have been made in order to better represent financial information

23. Accounting policies
23.1 Presentation of the financial statements
The consolidated financial statements as at September 30, 2024 were prepared in accordance with the historical cost method with the exception of derivatives, a few financial investments measured at fair value and assets and liabilities hedged against changes in fair value, as explained in more detail in this report, as well as on a going concern basis.
With regard to the financial statements, the following is specified:
- in the statement of financial position, the Group distinguishes between non-current and current assets and liabilities;
- in the income statement, the Group classifies costs by nature insofar as this is deemed to more accurately represent the primarily commercial and distribution activities carried out by the Group;
- comprehensive income statement: in addition to the net result for the year, it includes the effects of changes in exchange rates, the cash flow hedge reserve, the foreign currency basis spread reserve on derivative instruments and the actuarial gains and losses that have been recognized directly in changes in shareholders' equity, these items are divided according to whether or not they can be subsequently reclassified to the income statement;
- statement of changes in net equity: the Group reports all the changes in net equity, including those deriving from shareholder transactions (payment of dividends and capital increases);
- statement of cash flows: is prepared using the indirect method to determine cash flow from operations.
23.2 Use of estimates in preparing the financial statements
The preparation of the financial statements and explanatory notes requires the use of estimates and assumptions particularly with regard to the following items:
- revenues for services rendered over time recognized based on the effort or the input expended to satisfy the performance obligation;
- allowances for impairment made based on the asset's estimated realizable value;
- provisions for risks and charges made based on a reasonable estimate of the amount of the potential liability, including with regard to any counterparty claims;
- provisions for obsolete inventories in order to align the carrying value of inventories with the estimated realizable value;
- provisions for employee benefits, calculated based on actuarial valuations;
- amortization and depreciation of intangible assets and tangible fixed assets recognized based on the estimated remaining useful life and the recoverable amount;
- income tax recognized based on the best estimate of the tax rate for the full year;
- IRS and currency swaps (instruments not traded on regulated markets), marked to market at the reporting date based on the yield curve and market exchange rates, which are subject to credit/debit valuation adjustments based on market prices;

- the lease term duration was determined on a lease-by-lease basis and is comprised of the "non-cancellable" period along with the impact of any extension or early termination clauses if exercise of that clause is reasonably certain. This property valuation took into account circumstances and facts specific to each asset;
- discount rate of leases falling within the scope of IFRS 16 (incremental borrowing rate) determined based on the IRS (reference interbank rate used as an index for fixed-rate mortgage loans) in the individual countries in which Amplifon Group companies operate, for maturities commensurate with the duration of the specific rental contract, plus the Parent Company's credit spread and any costs for additional guarantees. In the rare instances when the IRS rate is not available (Egypt, Ecuador, Mexico and Panama), the risk-free rate was determined based on government bonds with maturities similar to the duration of the specific rental contract.
Estimates and assumptions are periodically reviewed, and any changes made, following the change of the circumstances or the availability of better information, are recognized in the income statement. The use of reasonable estimates is essential to the preparation of the financial statements and does not affect their overall reliability.
The Group verifies the existence of a loss in value of goodwill regularly once a year or in the event of impairment indicators.
The impairment test is conducted for the groups of cash generating units to which the goodwill refers and based on which the Group values, directly or indirectly, the return on the investment that includes the goodwill.

23.3 IFRS standards/interpretations
IFRS/interpretations approved by the IASB, endorsed in Europe and applied for the first time this year
The following table lists the IFRS/interpretations approved by the IASB, endorsed in Europe and applied for the first time this year.
| Description | Endorsement date |
Publication in the G.U.C.E. |
Effective date | Effective date for Amplifon |
|---|---|---|---|---|
| Amendments to IAS 1: "Presentation of Financial Statements: Classification of liabilities as current or non current", "Classification of Liabilities as Current or Non current - Deferral of Effective Date" and ''Non-current Liabilities with Covenants'' (issued on 23 January 2020, 15 July 2020 and 31 October 2022, respectively) |
19 Dec '23 | 20 Dec '23 | 1 Jan '24 | 1 Jan '24 |
| Amendments to IFRS 16 "Leases: Lease Liability in a Sale and Leaseback" (issued on 22 September 2022) |
20 Nov '23 | 21 Nov '23 | 1 Jan '24 | 1 Jan '24 |
| Amendments to IAS 7'Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures: Supplier Finance Arrangements' (issued on 25 May 2023) |
15 May 24 | 16 Jun '24 | 1 Jan '24 | 1 Jan '24 |
IAS 1 amendments are related to the definitions of current and non-current liabilities, providing a more generalized approach to the classification of liabilities under the standard, based on the contractual agreements. The amendments clarify the criteria for classifying a liability as current or non-current and require new disclosures in financial statements regarding non-current liabilities that include covenants to be satisfied within twelve months after the reporting period.
The Amplifon Group has applied the temporary exemption provided by the amendment to IAS 12, issued by the International Accounting Standards Board ("IASB") on 23 May 2023, regarding the recognition and related disclosure to be provided in the consolidated financial statements in relation to deferred tax assets and liabilities arising from the application of the minimum level of taxation ("Global Minimum Tax") provided by Directive (EU) 2022/2523 of 14 December 2022 (the "Directive"), under the Global Anti-Base Erosion Model Rules (Pillar Two).
Toward this end, on 28 December 2023, Legislative Decree No. 209 of 27 December 2023 implementing the international tax reform which came into effect on 29 December 2023, containing the Italian provisions related to Pillar Two, was published in the Official Gazette.

In light of the above, an analysis was carried out in order to estimate the potential impact of Pillar Two application on the Group in 2024. Based on this analysis, the Pillar Two rules should not have a material impact on the Group in 2024.
IFRS 16 amendments are related to the definitions of liabilities derived from leasebacks and the accounting treatment of any gains or losses stemming from these transactions.
IAS 7 and IFRS 7 amendments refer to the disclosure of information deemed relevant for the purposes of Supplier Finance Arrangements.The purpose of these amendments is to make it easier for financial statement users to understand the effects of these arrangements on liabilities, cash flows and exposure to liquidity risk.
The adoption of the standards and interpretations described above did not have a material impact on the measurement of the Group's assets, liabilities, costs, and revenues.
23.4 Future accounting standards and interpretations
IFRS standards/interpretations approved by IASB, but not endorsed in Europe
The following are the international accounting standards, interpretations, amendments to existing accounting standards and interpretations, or specific provisions contained in the standards and interpretations approved by the IASB which, at 21st October 2024, have yet to be endorsed for adoption in Europe.
| Description | Effective date | ||
|---|---|---|---|
| Amendments to IAS 21 "The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability" (issued on 15 August 2023) |
Periods beginning on or after 1 Jan '25 | ||
| Annual improvements volume 11 (issued on 18 July 2024) | Periods beginning on or after 1 Jan '26 | ||
| Amendments to IFRS 9 and IFRS7 "Classification and Measurement of Financial Instruments" (issued on 30 May 2024) |
Periods beginning on or after 1 Jan '26 |
IAS 7 amendments refer to the disclosure of information deemed relevant for the purposes of Supplier Finance Arrangements.
The amendments to IAS 21 proposed by IASB provide clarification as to exchange whether a currency is exchangeable and which exchange rate to be use if it is not.
The amendments to IFRS9 and IFRS7 proposed by IASB are related to the settlement of liabilities through electronic payment systems and to clarifying the classification of financial assets with environmental, social and corporate governance (ESG) and similar features.
The document Annual improvement. Volume 11 lists improvements limited to changes that either clarify the wording in an IFRS Accounting Standard, or correct relatively minor unintended consequences, oversights or conflicts between requirements of the Accounting Standards. In particular, the amendments relate to IFRS1, IFRS7, IFRS9, IFRS10 and IAS7.

The adoption of the standards and interpretations approved and not endorsed above is not expected to have a material impact on the measurement of the Group's assets, liabilities, costs and revenues.
The adoption of the standards and interpretations described above did not have a material impact on the measurement of the Group's assets, liabilities, costs, and revenues.

24. Subsequent events
As at 14 October 2024, Amplifon signed with UniCredit and Cassa Depositi e Prestiti (CDP) €200 million credit facility ESG linked with a 5-year term, divided as follows: €100 million from UniCredit to support the Group's development initiatives and €100 million from CDP which co-financed Amplifon's investments in innovation in Italy
After 30 September 2024, the Amplifon Group continued its external growth with the acquisition of 15 stores in China, 5 in France and 3 in the United States.
Milan, October 30th, 2024
CEO
Enrico Vita

Annexes
Annex I
Consolidation scope
As required by articles 38 and 39 of Law 127/91 and article 126 of Consob's resolution 11971 dated 14 May 1999, as amended by resolution 12475 dated 6 April 2000, the following is the list of companies included in the consolidation scope of Amplifon S.p.A. at 30 September 2024.
Parent company:
| Company name | Head office | Currency | Share capital |
|---|---|---|---|
| Amplifon S.p.A. | Milan (Italy) | EUR | 4,527,772 |
Subsidiaries consolidated using the line-by-line method:
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2024 |
|---|---|---|---|---|---|
| Amplifon Rete | Milano (Italy) | I | EUR | 19,250 | 2.6% |
| Amplifon Italia S.p.A. | Milano (Italy) | D | EUR | 100,000 | 100.0% |
| Amplifon France SAS | Arcueil (France) | D | EUR | 173,550,898 | 100.0% |
| SCI Eliot Leslie | Lyon (France) | I | EUR | 610 | 100.0% |
| New Ear SAS | Guidel (France) | I | EUR | 502,830 | 100.0% |
| Ghama EURL | Guidel (France) | I | EUR | 5,000 | 100.0% |
| Adagio SARL | Guidel (France) | I | EUR | 14,000 | 100.0% |
| Audition Guidel EURL | Guidel (France) | I | EUR | 1,500 | 100.0% |
| Labo Audio SAS | Libourne (France) | I | EUR | 50,000 | 100.0% |
| Audio Montfermeil SAS | Montfermeil (France) | I | EUR | 1,000 | 100.0% |
| Amplitude Audition SAS | Prades-le-Lez (France) | I | EUR | 1,000 | 100.0% |
| Boulben Audition – Majuni SAS | Queven (France) | I | EUR | 15,000 | 100.0% |
| OSX Solutions Auditives SAS | Vitry-Sur-Seine (France) | I | EUR | 1,000 | 100.0% |
| Nouvelle Audition SAS | Roquefort-Les-Pins (France) |
I | EUR | 5,000 | 100.0% |
| Ondes DBR SAS | Baillargues (France) | I | EUR | 3,000 | 100.0% |
| Audition Fontaine SAS | Barentin (France) | I | EUR | 100,000 | 100.0% |
| Armor audition SAS | Brest (France) | I | EUR | 7,622 | 100.0% |
| AFL audition Frank Lefevre SAS | Brest (France) | I | EUR | 200,000 | 100.0% |
| GFL audition SAS | Rennes (France) | I | EUR | 10,000 | 100.0% |
| Grousseau SAS | Beauvais (France) | I | EUR | 7,700 | 100.0% |
| Nadov Audition SAS | Juvisy (France) | I | EUR | 5,000 | 100.0% |
| Pastel Audiologie SAS | Villefranche de Lauragais (France) |
I | EUR | 835,970 | 100.0% |
| Pastel Audition SAS | Villefranche de Lauragais (France) |
I | EUR | 10,000 | 100.0% |
| Acoustiques des Halles SAS | Biarritz (France) | I | EUR | 80,000 | 100.0% |
| Audition Détente SAS | Saint-André-de-Sangonis (France) |
I | EUR | 2,222 | 100.0% |
| Belletente SAS | Saint-Étienne (France) | I | EUR | 6,000 | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2024 |
|---|---|---|---|---|---|
| Audiloire SAS | Tours (France) | I | EUR | 1,000 | 100.0% |
| L'Oreillette Du Mans SAS | Le Mans (France) | I | EUR | 10,800 | 100.0% |
| Aurissimans SAS | Savigné l'Eveque (France) | I | EUR | 6,000 | 100.0% |
| L'Effet L'Arsene | Tours (France) | I | EUR | 1,000 | 100.0% |
| François Audition | Ballan-Mire (France) | I | EUR | 3,000 | 100.0% |
| Audition Freres François | Tours (France) | I | EUR | 6,000 | 100.0% |
| FFF Audio | Chambray-Lès-Tours (France) |
I | EUR | 6,000 | 100.0% |
| Vouvray Audition | Vouvray (France) | I | EUR | 6,000 | 100.0% |
| Amplifon Ibérica, S.A.U. | Barcelona (Spagna) | D | EUR | 26,578,809 | 100.0% |
| Microson S.A. | Barcelona (Spagna) | D | EUR | 61,752 | 100.0% |
| Amplifon LATAM Holding, S.L.U. | Barcelona (Spagna) | I | EUR | 3,000 | 100.0% |
| Audifonos factory, S.L. | Malaga (Spain) | I | EUR | 3,000 | 100.0% |
| Audifonos sevillaudio, S.L. | Malaga (Spain) | I | EUR | 10,000 | 100.0% |
| Audio diagnostics, S.L. | Malaga (Spain) | I | EUR | 30,000 | 100.0% |
| Audio elite sur, S.L. | Malaga (Spain) | I | EUR | 20,000 | 100.0% |
| Audiolmenes, S.L. | Malaga (Spain) | I | EUR | 3,000 | 100.0% |
| Corbaudio centros auditivos, S.L. | Cordoba (Spain) | I | EUR | 3,000 | 100.0% |
| Talayoaudio, S.L.U. | Marbella (Spain) | I | EUR | 3,000 | 100.0% |
| Tecnoaudifonos, S.L.U. (*) | Malaga (Spain) | I | EUR | 6,000 | 100.0% |
| Audio nevada, S.L. | Malaga (Spain) | I | EUR | 10,000 | 100.0% |
| Audioliva, S.L. | Jaen (Spain) | I | EUR | 3,000 | 100.0% |
| Centro audio granada, S.L. | Granada (Spain) | I | EUR | 36,000 | 100.0% |
| Futurooigo, S.L. | Malaga (Spain) | I | EUR | 3,000 | 100.0% |
| Centro auditivo sent, S.L. | Granada (Spain) | I | EUR | 3,000 | 100.0% |
| Esteponaudio, S.L. | Estepona (Spain) | I | EUR | 3,000 | 100.0% |
| Recimetal cordoba, S.L. (*) | Marbella (Spain) | I | EUR | 23,095 | 100.0% |
| Soluciones auditivas de la subbetica, S.L. | Rute (Spain) | I | EUR | 3,000 | 100.0% |
| Soluciones auditivas y visuales gonzales, S.L. |
Malaga (Spain) | I | EUR | 29,000 | 100.0% |
| Soluciones profesionales de audiologia, S.L. |
Malaga (Spain) | I | EUR | 23,408 | 100.0% |
| Sonic technology españa, S.L. | Fuengirola (Spain) | I | EUR | 9,015 | 100.0% |
| Sontec centros auditivos, S.L. | Mijas (Spain) | I | EUR | 6,000 | 100.0% |
| Amplifon Portugal SA | Lisboa (Portogallo) | I | EUR | 15,520,187 | 100.0% |
| Amplifon Magyarország Kft | Budapest (Hungary) | D | HUF | 723,500,000 | 100.0% |
| Amplibus Magyarország Kft | Budaörs (Hungary) | I | HUF | 3,000,000 | 100.0% |
| Amplifon AG | Baar (Switzerland) | D | CHF | 1,000,000 | 100.0% |
| Amplifon Nederland B.V. | Doesburg (The Netherlands) |
D | EUR | 74,212,052 | 100.0% |
| Auditech B.V. | Doesburg (The Netherlands) |
I | EUR | 22,500 | 100.0% |
| Electro Medical Instruments B.V. | Doesburg (The Netherlands) |
I | EUR | 16,650 | 100.0% |
| Beter Horen B.V. | Doesburg (The Netherlands) |
I | EUR | 18,000 | 100.0% |
| Amplifon Customer Care Service B.V. | Elst (The Netherlands) | I | EUR | 18,000 | 100.0% |
| Amplifon Belgium N.V. | Bruxelles (Belgium) | D | EUR | 495,800 | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2024 |
|---|---|---|---|---|---|
| Amplifon RE SA | Lussemburgo (Luxembourg) |
D | EUR | 3,700,000 | 100.0% |
| Pilot Blankenfelde Medizinisch Elektronische Gerate GmbH |
Blankenfelde-Mahlow (Germany) |
D | EUR | 34,595 | 100.0% |
| Amplifon Deutschland GmbH | Hamburg (Germany) | D | EUR | 6,026,000 | 100.0% |
| Focus Hören AG | Willroth (Germany) | I | EUR | 485,555 | 100.0% |
| Focus hören Deutschland GmbH | Willroth (Germany) | I | EUR | 25,000 | 100.0% |
| Pavel Hören und Sehen GmbH & Co. KG | Münster (Germany) | I | EUR | 122,566 | 100.0% |
| Hörwelt Duisburg GmbH | Duisburg (Germany) | I | EUR | 25,000 | 100.0% |
| Amplifon Poland Sp. z o.o. | Lodz (Poland) | D | PLN | 3,348,280 | 100.0% |
| Amplifon UK Ltd | Manchester (United Kingdom) |
D | GBP | 130,951,168 | 100.0% |
| Amplifon Ltd | Manchester (United Kingdom) |
I | GBP | 1,800,000 | 100.0% |
| Ultra Finance Ltd | Manchester (United Kingdom) |
I | GBP | 75 | 100.0% |
| Amplifon Cell | Ta' Xbiex (Malta) | D | EUR | 2,500,125 | 100.0% |
| Medtechnica Ortophone Ltd (**) | Tel Aviv (Israel) | D | ILS | 1,100 | 90.0% |
| Amplifon Middle East SAE | Cairo (Egypt) | D | EGP | 3,000,000 | 51.0% |
| Miracle Ear Inc. | St. Paul (United States) | I | USD | 5 | 100.0% |
| Elite Hearing, LLC | Minneapolis (United States) |
I | USD | 1,000 | 100.0% |
| Amplifon Hearing Health Care. Inc. | St. Paul (United States) | I | USD | 10 | 100.0% |
| Ampifon IPA, LLC | New York (United States) | I | USD | - | 100.0% |
| Amplifon USA Inc. | Dover (United States) | D | USD | 52,500,010 | 100.0% |
| METX, LLC | Waco (United States) | I | USD | - | 100.0% |
| MEFL, LLC | Waco (United States) | I | USD | - | 100.0% |
| METampa, LLC | Waco (United States) | I | USD | - | 100.0% |
| MENM, LLC | Waco (United States) | I | USD | - | 100.0% |
| ME Flagship, LLC | Wilmington (United States) | I | USD | - | 100.0% |
| ME Pivot Holdings, LLC | Minneapolis (United States) |
I | USD | 2,000,000 | 100.0% |
| MEOH, LLC | Minneapolis (United States) |
I | USD | - | 100.0% |
| Miracle Ear Canada Ltd. | Vancouver (Canada) | I | CAD | 169,601,200 | 100.0% |
| 2829663 Ontario Inc (*) | Milton (Canada) | I | CAD | - | 100.0% |
| Raindrop Hearing Clinic Inc. (*) | Toronto (Canada) | I | CAD | - | 100.0% |
| The Hearing Clinic (*) | Scarborough (Canada) | I | CAD | - | 100.0% |
| Lisa Reid Audiology Hearing Centres (*) | Manitoba (Canada) | I | CAD | - | 100.0% |
| Great to Hear, Inc. (*) | Manitoba (Canada) | I | CAD | - | 100.0% |
| Living Sounds Hearing Centre Ltd. (*) | Alberta (Canada) | I | CAD | - | 100.0% |
| Professional Hearing Services Ltd./100391416 Ontario Ltd. (*) |
Ontario (Canada) | I | CAD | - | 100.0% |
| Sackville Hearing Centre Limited (*) | Nova Scotia (Canada) | I | CAD | - | 100.0% |
| Hometown Hearing Centre Inc (*) | Bancroft (Canada) | I | CAD | - | 100.0% |
| Newlife Hearing Inc. (*) | St. John's (Canada) | I | CAD | - | 100.0% |
| Provincial Hearing Aid Service (Halifax) Ltd. (*) |
Halifax (Canada) | I | CAD | - | 100.0% |
| Audia Hearing Aid Centre Inc. (*) | Ontario (Canada) | I | CAD | - | 100.0% |
| The Hearing Institute of Ontario, Inc. (*) | Ontario (Canada) | I | CAD | - | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2024 |
|---|---|---|---|---|---|
| Rupert Hearing Ltd (*) | Prince Rupert (Canada) | I | CAD | - | 100.0% |
| Pure Audiology & Hearing Aid Services, Inc. (*) |
Oakville (Canada) | I | CAD | - | 100.0% |
| GAES S.A. (Chile) | Santiago de Chile (Chile) | I | CLP | 1,901,686,034 | 100.0% |
| GAES Servicios Corporativo de Latinoamerica SpA |
Santiago de Chile (Chile) | I | CLP | 10,000,000 | 100.0% |
| Audiosonic Chile S.A. | Santiago de Chile (Chile) | I | CLP | - | 99.0% |
| GAES S.A. (Argentina) | Buenos Aires (Argentina) | I | ARS | 120,542,331 | 100.0% |
| GAES Colombia S.A.S. | Bogotà (Colombia) | I | COP | 22,000,000,000 | 100.0% |
| Audiovital Cìa. Ltda. | Quito (Ecuador) | I | USD | 430,337 | 100.0% |
| Centros Auditivos GAES Mexico sa de cv | Ciudad de México (Mexico) | I | MXN | 276,477,133 | 100.0% |
| Compañía de Audiologia y Servicios Medicos sa de cv |
Aguascalientes (Mexico) | I | MXN | 43,306,212 | 100.0% |
| GAES Panama S.A. | Panama (Panama) | I | PAB | 510,000 | 100.0% |
| Audical S.A.S | Montevideo (Uruguay) | D | UYU | 500,000 | 100.0% |
| Centro Auditivo S.A.S | Montevideo (Uruguay) | D | UYU | 500,000 | 100.0% |
| Ikako S.A. | Montevideo (Uruguay) | D | UYU | 100,000 | 100.0% |
| Amplifon Australia Holding Pty Ltd | Sydney (Australia) | D | AUD | 392,000,000 | 100.0% |
| National Hearing Centres Pty Ltd | Sydney (Australia) | I | AUD | 100 | 100.0% |
| National Hearing Centres Unit Trust | Sydney (Australia) | I | AUD | - | 100.0% |
| Otohub Unit Trust (in liquidazione) | Brisbane (Australia) | D | AUD | - | 100.0% |
| Otohub Australasia Pty Ltd | Brisbane (Australia) | D | AUD | 10 | 100.0% |
| Attune Hearing Pty Ltd | Brisbane (Australia) | D | AUD | 14,771,093 | 100.0% |
| Attune Workplace Hearing Pty Ltd | Brisbane (Australia) | I | AUD | 1 | 100.0% |
| Ear Deals Pty Ltd | Brisbane (Australia) | I | AUD | 300,000 | 100.0% |
| Bay Audio Pty Ltd | Sydney (Australia) | D | AUD | 10,000 | 100.0% |
| Amplifon Asia Pacific Pte Limited | Singapore (Singapour) | I | SGD | 1,000,000 | 100.0% |
| Auckland Hearing Ltd | Auckland (New Zealand) | I | NZD | - | 100.0% |
| Amplifon NZ Ltd | Takapuna (New Zealand) | I | NZD | 130,411,317 | 100.0% |
| Bay Audiology Ltd | Takapuna (New Zealand) | I | NZD | - | 100.0% |
| Dilworth Hearing Ltd | Auckland (New Zealand) | I | NZD | - | 100.0% |
| Amplifon India Pvt Ltd | Gurgaon (India) | I | INR | 2,050,000,000 | 100.0% |
| Beijing Amplifon Hearing Technology Center Co., Ltd |
Běijīng (China) | D | CNY | 2,143,685 | 100.0% |
| Tianjin Amplifon Hearing Technology Co., Ltd |
Tianjin (China) | I | CNY | 3,500,000 | 100.0% |
| Shijiazhuang Amplifon Hearing Technology Center Co. Ltd |
Shijiazhuang (China) | I | CNY | 100,000 | 100.0% |
| Amplifon (China) Investment Co., Ltd | Shanghai (China) | D | CNY | 608,750,000 | 100.0% |
| Hangzhou Amplifon Hearing Aid Co., Ltd | Hangzhou (China) | D | CNY | 11,000,000 | 100.0% |
| Zhengzhou Yuanjin Hearing Technology Co., Ltd. |
Zhengzhou (China) | I | CNY | - | 100.0% |
| Wuhan Amplifon Hearing Aid Co., Ltd | Wuhan (China) | I | CNY | 40,000,000 | 100.0% |
| Shanghai Amplifon Hearing Technology Co. Ltd, |
Shanghai (China) | I | CNY | 50,000,000 | 100.0% |
| Nanjing Amplifon Hearing Aid Co., Ltd | Nanjing (China) | I | CNY | 15,000,000 | 100.0% |
| Shanxi Amplifon Hearing Aid Co., Ltd. | Taiyuan (China) | I | CNY | 30,000,000 | 100.0% |
| Henan Amplifon Hearing Aid Co., Ltd. | Luoyang (China) | I | CNY | 1,000,000 | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2024 |
|---|---|---|---|---|---|
| Fuzhou Tingan Medical Device Co., Ltd | Fuzhou (China) | I | CNY | 20,000,000 | 100.0% |
| Chongqing Amplifon Hearing Aids Co., Ltd. |
Chongqing (China) | I | CNY | 10,000,000 | 100.0% |
| Sichuan Amplifon Hearing Aid Co., Ltd. | Chengdu (China) | I | CNY | 24,000,000 | 100.0% |
| Xi'an Ansheng Medical Equipment Co., Ltd. |
Xi'an (China) | I | CNY | 16,000,000 | 100.0% |
| Ningxia Listening Shunan Medical Equipment Co., Ltd |
Yinchuan (China) | I | CNY | 16,000,000 | 100.0% |
| Yunnan Amplifon Hearing Aid Co., Ltd. | Kunming (China) | I | CNY | 16,000,000 | 100.0% |
| Shanxi Amplifon Hearing Aid Business Co., Ltd |
Xi'an (China) | I | CNY | 18,000,000 | 100.0% |
| Anhui Amplifon Hearing Aid business Co., Ltd. |
Ma'anshan (China) | I | CNY | 30,000,000 | 100.0% |
| AnLaiSheng (Inner Mongolia) Medical Equipment Co.Ltd |
Hohhot (China) | I | CNY | 47,000,000 | 100.0% |
(*) Medtechnica Ortophone Ltd, despite being 90% owned by Amplifon, is consolidated at 100% without exposure of non-controlling interests due to the put-call option exercisable from 2019 and related to the purchase of the remaining 10%. (**) Dormant companies
Companies valued using the equity method:
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital |
% held as at 09/30/2024 |
|---|---|---|---|---|---|
| Comfoor BV (*) | Doesburg (The Netherlands) |
I | EUR | 18,000 | 50.0% |
| Comfoor GmbH (*) | Emmerich am Rhein (Germany) |
I | EUR | 25,000 | 50.0% |
| Ruti Levinson Institute Ltd (**) | Ramat HaSharon (Israel) |
I | ILS | 105 | 20.0% |
| Afik - Test Diagnosis & Hearing Aids Ltd (**) |
Jerusalem (Israel) | I | ILS | 100 | 20.0% |
| Lakeside Specialist Centre Ltd (**) | Mairangi Bay (New Zealand) |
I | NZD | - | 50.0% |
(*) Joint Venture
(**) Related companies

Declaration in respect of the Consolidated Financial Statements pursuant to Article 154-bis of Legislative Decree no. 58/98
We, the undersigned, Enrico Vita, Chief Executive Officer and Gabriele Galli, Executive Responsible for Corporate Accounting Information for Amplifon S.p.A., taking into account the provisions of article 154-bis, paragraphs 3 and 4 of Law no. 58/98, certify:
- the adequacy, by reference to the characteristics of the business and
- the effective application of the administrative and accounting procedures for the preparation of the condensed interim consolidated financial statements during the period 1 January – 30 September 2024.
We also certify that the condensed interim consolidated financial statements at 30 September 2024:
- have been prepared in accordance with the international accounting standards recognized in the European Union under the EC regulation no. 1606/2002 of the European Parliament and of the Council of 19 July 2002;
- correspond to the underlying accounting entries and records;
- provides a true and fair view of the performance and financial position of the issuer and of all of the companies included in the consolidation area.
The report on operations includes a reliable operating and financial review of the Company and all of the companies included in the consolidation area.
Milan, October 30th, 2024
CEO Executive Responsible for Corporate Accounting Information
Enrico Vita Gabriele Galli